JPS637549B2 - - Google Patents
Info
- Publication number
- JPS637549B2 JPS637549B2 JP56116322A JP11632281A JPS637549B2 JP S637549 B2 JPS637549 B2 JP S637549B2 JP 56116322 A JP56116322 A JP 56116322A JP 11632281 A JP11632281 A JP 11632281A JP S637549 B2 JPS637549 B2 JP S637549B2
- Authority
- JP
- Japan
- Prior art keywords
- dianhydro
- nitrate
- compound
- glucito
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims abstract description 100
- 150000003839 salts Chemical class 0.000 claims abstract description 47
- -1 methanesulphonyl Chemical group 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 16
- 125000001997 phenyl group Chemical class [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 66
- 229910002651 NO3 Inorganic materials 0.000 claims description 57
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 46
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic acid anhydride Natural products CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 46
- 239000011664 nicotinic acid Substances 0.000 claims description 40
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 38
- 239000002253 acid Substances 0.000 claims description 32
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 26
- 229910017604 nitric acid Inorganic materials 0.000 claims description 26
- 229960000583 acetic acid Drugs 0.000 claims description 17
- KLDXJTOLSGUMSJ-JGWLITMVSA-N Isosorbide Chemical compound O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-JGWLITMVSA-N 0.000 claims description 14
- KLDXJTOLSGUMSJ-UNTFVMJOSA-N (3s,3ar,6s,6ar)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3,6-diol Chemical compound O[C@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-UNTFVMJOSA-N 0.000 claims description 11
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 11
- 229960002479 isosorbide Drugs 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 7
- ATBIAJXSKNPHEI-UHFFFAOYSA-N pyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=CN=C1 ATBIAJXSKNPHEI-UHFFFAOYSA-N 0.000 claims description 7
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 6
- 230000032050 esterification Effects 0.000 claims description 6
- 238000005886 esterification reaction Methods 0.000 claims description 6
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 claims description 6
- 230000001546 nitrifying effect Effects 0.000 claims description 6
- 238000006467 substitution reaction Methods 0.000 claims description 6
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims description 5
- 239000012362 glacial acetic acid Substances 0.000 claims description 5
- 235000001968 nicotinic acid Nutrition 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 125000005059 halophenyl group Chemical group 0.000 claims description 4
- 230000003276 anti-hypertensive effect Effects 0.000 claims description 3
- 239000000010 aprotic solvent Substances 0.000 claims description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 2
- 230000002921 anti-spasmodic effect Effects 0.000 claims 1
- 239000000812 cholinergic antagonist Substances 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 230000020477 pH reduction Effects 0.000 claims 1
- 150000002989 phenols Chemical class 0.000 claims 1
- 239000003586 protic polar solvent Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 84
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 30
- 239000000243 solution Substances 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 238000003756 stirring Methods 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- 238000000921 elemental analysis Methods 0.000 description 14
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000001816 cooling Methods 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 10
- MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 10
- 229960000201 isosorbide dinitrate Drugs 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000000284 extract Substances 0.000 description 7
- YWXYYJSYQOXTPL-SLPGGIOYSA-N isosorbide mononitrate Chemical compound [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-SLPGGIOYSA-N 0.000 description 7
- 229960003827 isosorbide mononitrate Drugs 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- 238000001953 recrystallisation Methods 0.000 description 7
- 235000017557 sodium bicarbonate Nutrition 0.000 description 7
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 239000002026 chloroform extract Substances 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 241000282326 Felis catus Species 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- KFLRWGSAMLBHBV-UHFFFAOYSA-M sodium;pyridine-3-carboxylate Chemical compound [Na+].[O-]C(=O)C1=CC=CN=C1 KFLRWGSAMLBHBV-UHFFFAOYSA-M 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 210000004351 coronary vessel Anatomy 0.000 description 3
- 150000002823 nitrates Chemical class 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical class CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 206010047115 Vasculitis Diseases 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000002360 explosive Substances 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 230000000297 inotrophic effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- SXAMGRAIZSSWIH-UHFFFAOYSA-N 2-[3-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,2,4-oxadiazol-5-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NOC(=N1)CC(=O)N1CC2=C(CC1)NN=N2 SXAMGRAIZSSWIH-UHFFFAOYSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- MXJBIALFHGDUPE-UHFFFAOYSA-N 4-chlorophenol;sodium Chemical compound [Na].OC1=CC=C(Cl)C=C1 MXJBIALFHGDUPE-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 229910020366 ClO 4 Inorganic materials 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 206010052895 Coronary artery insufficiency Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000008238 Muscle Spasticity Diseases 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000009298 Trigla lyra Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000003257 anti-anginal effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 210000002376 aorta thoracic Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- MGHMNKBPWSKDKH-UHFFFAOYSA-N benzoic acid;nitric acid Chemical class O[N+]([O-])=O.OC(=O)C1=CC=CC=C1 MGHMNKBPWSKDKH-UHFFFAOYSA-N 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 238000012658 bimolecular nucleophilic substitution Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 150000004648 butanoic acid derivatives Chemical class 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- OJYGBLRPYBAHRT-IPQSZEQASA-N chloralose Chemical compound O1[C@H](C(Cl)(Cl)Cl)O[C@@H]2[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]21 OJYGBLRPYBAHRT-IPQSZEQASA-N 0.000 description 1
- 229950009941 chloralose Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000000990 duodenal loop Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000006345 epimerization reaction Methods 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000002350 laparotomy Methods 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 125000000627 niacin group Chemical group 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- RNPNPEKBPDIYQF-UHFFFAOYSA-N nitric acid;pyridine-3-carboxylic acid Chemical compound O[N+]([O-])=O.OC(=O)C1=CC=CN=C1 RNPNPEKBPDIYQF-UHFFFAOYSA-N 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 230000001148 spastic effect Effects 0.000 description 1
- 208000018198 spasticity Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- IMCGHZIGRANKHV-AJNGGQMLSA-N tert-butyl (3s,5s)-2-oxo-5-[(2s,4s)-5-oxo-4-propan-2-yloxolan-2-yl]-3-propan-2-ylpyrrolidine-1-carboxylate Chemical compound O1C(=O)[C@H](C(C)C)C[C@H]1[C@H]1N(C(=O)OC(C)(C)C)C(=O)[C@H](C(C)C)C1 IMCGHZIGRANKHV-AJNGGQMLSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
ãã®çºæã¯äžè¬åŒ
ïŒããã§ãã¯ããã²ã³çœ®æããšãã«åºãã¡ã¿
ã³ã¹ã«ããã«åºãŸãã¯ãã³ããã€ã«åºïŒã§ç€ºãã
ãïŒâããã³ïŒâ眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢
ã³ãããããã·ããã¢ããã€ãã¬ãŒãååç©äžŠã³
ã«ïŒ²ããã³ããã€ã«åºã«ããããã®ççåŠçã«èš±
容ã§ããé žä»å å¡©ã«é¢ããã ãããååç©ã®åºæ¬æ§é ã¯ãšãåã«ãã€ãŠçžäº
ã«è»¢åãåŸãç«äœç°æ§ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããããã·ãããããªãã¡åŒ ã§ç€ºãããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââ
ã€ãžããïŒã€ãœã€ãžãïŒïŒããã§ã¯ãïŒäœããã³
ïŒäœã®åOHåºã¯ãšããœåœ¢ããšã€ãŠããïŒããã³
åŒ ã§ç€ºãããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââ
ã°ã«ã·ããïŒã€ãœãœã«ããïŒïŒããã¯ãïŒäœã«ãš
ããœæ¹åã«ç«ã¡äžãã€ãOHåºããã³ïŒäœã«ãšã³
ãæ¹åã«ç«ã¡äžãã€ãOHåºãæã€ãŠããããã
ãã€ãŠãïŒäœããã³ïŒäœã«ç°ãªã眮æåºãååšã
ãå ŽåïŒã€ã®ç°æ§äœãååšãããïŒã®ããããäž
æ¹ãããªãã ãŸããããã€ãã®ååç©ã®åºæ¬æ§é ã¯åŒ ã§ç€ºãããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââ
ãã³ãããïŒã€ãœãã³ããïŒãããªããããã¯ãš
ã³ãæ¹åã«ç«ã¡äžãã€ãïŒã€ã®OHåºãæã€ãŠã
ãã ã°ã«ã·ããèªå°äœãšå¯Ÿæ¯ããŠã¿ããšã€ãžããã
ãã³ãã³ãããèªå°äœã®å Žåã¯ãïŒäœããã³ïŒäœ
ã®çœ®æåºã®éã«ã¯å·®ã¯ãªããïŒäœã®ïŒ£ååã¯åå
ã180ãå転ãããããšã«ãã€ãŠïŒäœã®ïŒ£ååãšãª
ãããã§ããããããèªå°äœã®å Žåã«ã¯çœ®æåºã«
ã€ããŠïŒäœãšãïŒäœãšãããå¿ èŠã¯ãªããããã
ãªãããåã ã®ååç©ã®æ§é ãäžè¬åŒãšãããã
察æ¯ãããããã«ãã€ãœã€ãžãèªå°äœããã®æ现
æžã§ã¯ïŒâäœçœ®æã€ãœã€ãžãèªå°äœãšåŒã¶ããš
ãšããããããã¯ç«äœé 眮ã®é転ã䌎ãªã€ãŠèŠªæ ž
眮æåå¿ã«ãã€ãŠäŸãã°ïŒââã¢ã«ãã«ã¹ã«ã
ãã«ã€ãœãœã«ãããŸãã¯ïŒâã¢ãªãŒã«ã¹ã«ãã
ã«ã€ãœãœã«ããããåŸãããšãã§ããããã§ã
ãã ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããããã·ããã®ç«
äœç°æ§ã«ã€ããŠã®ç°¡åãªæŠèŠãJ.A.ãã«ãº
ïŒMillsïŒã«ãã€ãŠã¢ãããŒã³ã·ãºã»ã€ã³ã»ã«ãŒã
ãã€ãã¬ãŒãã»ã±ãã¹ããªãŒã10 ïŒã53ïŒ1955ïŒ
ã«ç€ºãããŠããã ãã®çºæã¯åãã«è¿°ã¹ãïŒâããã³ïŒâ眮
æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããããã·ããã¢ã
ãã€ãã¬ãŒãã®è£œé æ¹æ³ããã³è¬å€çµæç©ã«ãé¢
ãããã®ã§ããã ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ã
ãïŒïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââãœã«ã
ãããšãåŒã°ããïŒã®ãã€ãã¬ãŒãïŒããªãã¡ïŒ
âã¢ããã€ãã¬ãŒãããã³ïŒâã¢ããã€ãã¬ãŒã
ã°ããã§ãªãïŒïŒïŒâãžãã€ãã¬ãŒããïŒã¯äŸã
ã°ç±³åœç¹èš±ç¬¬3886186å·ã«èšèŒãããŠããããã
ããã€ãã¬ãŒããç¹ã«ãžãã€ãã¬ãŒãïŒããã¯è¬
å€ãšããŠåžè²©ãããŠããïŒã¯è¡è¡ååŠçãè¡ç®¡æ¡
匵æ§ããã³æçå¿çæ§å¹æãæããè¬çåŠç掻æ§
ç©è³ªã§ãããç¹ã«å ç¶åèäžå šãçå¿çã®æ²»çã«
çšããããŠããã ããã«ãç±³åœç¹èš±ç¬¬3886186å·ã«ã¯ãã€ãœãœã«
ããã®ïŒâã¢ã»ããŒãâïŒâãã€ãã¬ãŒããïŒâ
ã¢ã»ããŒãâïŒâãã€ãã¬ãŒããïŒâãšãã¬ãŒã
âïŒâãã€ãã¬ãŒããïŒâãã€ãã¬ãŒãâïŒâã¹
ã«ãã¢ã¡ãŒããïŒâã«ã«ãã¡ãŒãâïŒâãã€ãã¬
ãŒãããã³ïŒâã«ã«ãã¡ãŒãâïŒâãã€ãã¬ãŒ
ããããã«ã¯çžå¿ããããããªããŒããããã¬ãŒ
ããã€ãœããã¬ãŒããã«ãããšãŒãããã³ãã³ãŸ
ãšãŒãã¢ããã€ãã¬ãŒãã瀺ãããŠããã ããã«ãŸããã€ãœã€ãžããã€ãœãœã«ããããã³
ã€ãœãã³ããã®ã¢ããã€ãã¬ãŒãã®ïœâãã«ãšã³
ã¹ã«ãã³é žãšã¹ãã«ãç¥ãããŠããïŒCan.J.
Chem.ïŒ45ïŒ2191ã2194ïŒ1967ïŒåç §ãããããª
ããããããååç©ã®èµ€å€ç·åžåã¹ãã¯ãã«ã ã
ã詳ããèšãããŠããã ãã§ããããããååç©
ã®è¬çåŠçæ§è³ªã«ã€ããŠã¯äœãç¥ãããŠããªãã ã€ãœãœã«ãããã€ãœãã³ããããã³ã€ãœã€ãžã
ã®ãžãã€ãã¬ãŒãããã³ã¢ããã€ãã¬ãŒãã®åæ
è¬çåŠã«ã€ããŠã¯ãã¬ãšã«ãããã³ããã»ã«ã«ã
ã€ãŠNaunynâSchmiedeberg's Arch.
Pharmacol.ïŒ275ïŒ339ïŒ1972ïŒã«èšèŒãããŠã
ãã ããããªãããäžèšãã€ãã¬ãŒãã¯äžå¿«ãªå¯äœ
çšç¹ã«é çãåŒãèµ·ãããšãç¥ãããŠããããŸ
ããã¢ããã€ãã¬ãŒãã¯äŸãã°ã€ãœãœã«ãããžã
ã€ãã¬ãŒãïŒISDNïŒãããååžåæ§ããããã
ããã«ã€ãœãœã«ãããã€ãœãã³ããããã³ã€ãœã€
ãžãã®ãžãã€ãã¬ãŒãã¯ççºæ§ã§ããã®ã§ãã®è£œ
é ããã³åæ±ãã«ã¯ç¹å¥ã®äºé²æªçœ®ãè¬ããªãã
ã°ãªããªãã ãããã€ãŠã掻æ§ã¹ãã¯ãã«ïŒç¯å²ïŒãåãã§
ã¯ãããäžèšäžå©ç¹ã®ãªãæ°èŠãªè¬å€ããã³ãã®
ãããªè¬å€ã®æå¹æåãšããŠäœ¿çšã§ããæ°èŠãª
ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããããã·ããã¢ãã
ã€ãã¬ãŒãã«å¯ŸããèŠæ±ããªãããŠããã ãã®çºæã¯äžèšèŠæ±ã«çãããã®ã§ãã€ãŠãæ°
èŠãªååç©ãæäŸãããã®ã§ããã ããªãã¡ããã®çºæã¯äžè¬åŒ ã§ç€ºãããïŒâ眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããââã€ãžããâïŒâãã€ãã¬ãŒããäžè¬åŒ ã§ç€ºãããïŒâ眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããââã°ã«ã·ããâïŒâãã€ãã¬ãŒããäžè¬
åŒ ã§ç€ºãããïŒâ眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããââã°ã«ã·ããâïŒâãã€ãã¬ãŒãããã
ã³äžè¬åŒ ã§ç€ºãããïŒâ眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããââãã³ãããâïŒâãã€ãã¬ãŒãïŒäžèš
äžè¬åŒïŒïŒãïŒïŒã«ãããŠãã¯ããã²ã³çœ®
æããšãã«åºãã¡ã¿ã³ã¹ã«ããã«åºãŸãã¯ãã³ã
ãã€ã«åºïŒã䞊ã³ã«ïŒ²ããã³ããã€ã«åºã«ããã
ãã®ççåŠçã«èš±å®¹ã§ããé žä»å å¡©ãæäŸããã
ã®ã§ããã ãã®çºæã®ååç©ã¯å åèæµå¢å€§æ§ãéçæ§ã
è¡å§éäžæ§ãçå€åäœçšé°æ§ããã³å¿ææ°äœäžæ§
çã®å¹æãæã€ããããååç©ã¯å åèçã®åŠ
眮ãçå¿çæ§çºäœã®åŠçœ®ããã³äºé²ãå¿çæ¢å¡ã®
åŸåŠçœ®ã䞊ã³ã«å¿äžå šã®åŠçœ®ã«å¥œé©ã§ããããŸ
ãããã®çºæã®ååç©ã¯æ²»çç¯å²ãè¯å¥œã§ããã
çµå£çåžåãç¹ã«è¯å¥œã§ããããŸãäœçšæéãé·
ããããã«ããããååç©ã¯æ«çšè¡æµããã³è³è¡
æµã®æ¹åãããããã ãã®çºæã®ååç©ã¯ççºæ§ã§ã¯ãªãã®ã§ããã®
補é ããã³åæ±ãã«ãããŠäŸãã°å ¬ç¥ã®ISDNã®
å Žåãããã¯ããã«å±éºæ§ãå°ãªãã ïŒïŒïŒïŒïŒïŒïŒâãžã¢ãœãããããããã®åºæ¬
æ§é ã«ãããŠããã®çºæã®ååç©ã¯ïŒåã®äžæç
çŽ ååãæã¡ãå åŠæŽ»æ§ã®åœ¢æ ã§ååšãããåºçº
ç©è³ªãšããŠã倩ç¶ã«ååšããç³ã¢ã«ã³ãŒã«ãã容
æã«åŸããããšããã®å åŠçã«çŽç²ãªïŒïŒïŒïŒ
ïŒïŒïŒâãžã¢ã³ãããããã·ãããçšããããŠã
ãããã§ããã ãã®çºæã®ååç©ã¯ãšã圢ã®æªçœ®æïŒïŒïŒïŒ
ïŒïŒïŒâãžã¢ã³ãããããã·ãããããããªãã¡
âã€ãœã€ãžããâã€ãœãœã«ããããã³ïŒ€âã€
ãœãã³ããããåºçºããŠä»¥äžã«ç€ºãæ§ã ãªåŸè·¯ã§
補é ã§ããã åèšäžè¬åŒïŒïŒã§ç€ºãããååç©ã§ãã€ãŠïŒ²
ãã¡ã¿ã³ã¹ã«ããã«åºãŸãã¯ãã³ããã€ã«åºã§ã
ããã®ã補é ããããã®ç¬¬ïŒã®æ¹æ³ã¯ããŸãçžå¿
ããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããããã·ããã
ç¡é žãç¡åæ§é žããŸãã¯ç¡é žãšé ¢é žç¡æ°Žç©ïŒé ¢é ž
ãšã®æ··åç©ã§ãå Žåã«å¿ããŠå°¿çŽ ã®ååšäžã«ãšã¹
ãã«åããããšãããªããããã«ãã€ãŠãçžå¿ã
ãã¢ããã€ãã¬ãŒãããã³ãžãã€ãã¬ãŒãã®æ··å
ç©ãåŸãããããžãã€ãã¬ãŒãã®å²åãã§ããã
ãäœãæããããã«ãç¡é žãšã€ãœããã·ããšã®å²
åãåŸè ïŒã¢ã«ã«ã€ãåè ã0.5ãªããïŒã¢ã«ãš
ãªãããã«ããããšã奜ãŸãããåŸãããã¢ãã
ã€ãã¬ãŒããšãžãã€ãã¬ãŒããšã®æ··åç©ããšãŒã
ã«ã§åŠçããæ°Žã§æœåºãããšãã¢ããã€ãã¬ãŒã
ã¯æ°Žçžããåé¢ã§ããäžæ¹äžææã®ãžãã€ãã¬ãŒ
ãã¯ãšãŒãã«çžäžã«å®å šã«æ®ããã€ãœãœã«ããã
ãšã¹ãã«åããå Žåãåå¿çæç©ãã·ãªã«ã²ã«ã
çšããã«ã©ã ã¯ãããã°ã©ãæ³ã«ãã€ãŠåé¢ãã
ããšãæå©ã§ããããã®åé¢æ¹æ³ã«ããã°ããžã
ã€ãã¬ãŒããå®å šã«åé¢ãããã°ããã§ãªããïŒ
çš®é¡ã®ã¢ããã€ãã¬ãŒãããªãã¡ã€ãœãœã«ããïŒ
ïŒãšã³ãïŒâãã€ãã¬ãŒãããã³ã€ãœãœã«ããïŒ
ïŒãšããœïŒãã€ãã¬ãŒããçžäºã«åé¢ãããã ã€ãã§ãçžå¿ããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãã
ãããã·ããã¢ããã€ãã¬ãŒããææã®é žã¯ããª
ãïŒã¡ã¿ã³ã¹ã«ãã³é žã¯ããªããŸãã¯ãã³ãã³é ž
ã¯ããªãïŒãšåå¿ãããŠææã®ååç©ãåŸããã
ã®ç¬¬ïŒã®æ¹æ³ã«ããã°ãäŸãã°ãïŒïŒïŒïŒïŒïŒïŒ
âãžã¢ã³ãããââã€ãžãããç¡é žã§ãšã¹ãã«
åããåŸãããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã€ãžããâïŒâãã€ãã¬ãŒãããã³ãã³é žã¯
ããªããšåå¿ãããããšã«ãã€ãŠïŒïŒïŒïŒïŒïŒïŒ
âãžã¢ã³ãããââã€ãžããâïŒâãã€ãã¬ãŒ
ãâïŒâãã³ãããŒããåŸãããã äžè¬åŒïŒïŒã§ç€ºãããååç©ã§ãã€ãŠïŒ²ãã¡
ã¿ã³ã¹ã«ããã«åºãŸãã¯ãã³ããã€ã«åºã§ããã
ã®ã補é ããããã®ç¬¬ïŒã®æ¹æ³ã¯ããŸããçžå¿ã
ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããããã·ãããæ
æã®é žã¯ããªãïŒã¡ã¿ã³ã¹ã«ãã³é žã¯ããªããŸã
ã¯ãã³ã³é žã¯ããªãïŒãšåå¿ãããããšãããª
ããããã«ãã€ãŠãçžå¿ãããžãšã¹ãã«ããã³ã¢
ããšã¹ãã«ã®æ··åç©ãåŸããããããåå¥çµæ¶ã
åå¥æœåºãããã¯ãã®ä»ã®æ段ã§åé¢ãããã€ã
ã§ãææã®ã¢ããšã¹ãã«ãç¡é žã§ãšã¹ãã«åããŠ
ææã®ååç©ãåŸãã ãã®ç¬¬ïŒã®æ¹æ³ã«åŸã€ãŠãäŸãã°ãïŒïŒïŒïŒ
ïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ããããåºçº
ããŠã¡ã¿ã³ã¹ã«ãã³é žã¯ããªããšåå¿ããããšã
ãŸããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«
ã·ããâïŒâã¡ã¿ã³ã¹ã«ãããŒããçæãããã
ãç¡é žãç¡åæ§é žããŸãã¯ç¡é žãæ°·é ¢é žããã³ç¡
æ°Žé ¢é žã®æ··åç©ãšåå¿ããããšïŒïŒïŒïŒïŒïŒïŒâ
ãžã¢ã³ãããââã°ã«ã·ããâïŒâãã€ãã¬ãŒ
ãâïŒâã¡ã¿ã³ã¹ã«ãããŒããåŸãããã äžè¬åŒïŒïŒã§ç€ºãããååç©ã§ãã€ãŠïŒ²ãã
ãããšãã«åºã§ãããã®ã補é ããããã«ã¯ããŸ
ããåå¿æ§ã€ãœããã·ãã¢ãã¢ã·ã«åç©å¥œãŸãã
ã¯ïŒåèšæ¹æ³ã«æºããŠïŒã€ãœããã·ãã¢ãã¡ã¿ã³
ã¹ã«ãããŒããŸãã¯ã€ãœããã·ãã¢ããã«ãšã³ã¹
ã«ãããŒãã補é ãããããäŸãã°ïœâã¯ããã
ãšããŒã«ãããªãŠã å¡©ã®ãããªææããããšããŒ
ã«ã®é©åœãªå¡©ïŒããã¯çžå¿ããããããšããŒã«ã«
ãããã³å容äœäŸãã°æ°ŽçŽ åãããªãŠã ãæ·»å ã
ãããšã«ãã€ãŠåå¿éçšã®ãã®å Žã§ã補é ã§ã
ãïŒãšåå¿ãããŠææã®ããããšãã«ãšãŒãã«ã
åŸããããããŠåŸãã€ãœããã·ãã®ããããšãã«
ãšãŒãã«ããæ¢è¿°ã®ããã«ãç¡é žã§ãšã¹ãã«åã
ãŠã¢ããã€ãã¬ãŒããåŸããããããšãã«åºã®ç¡
åãé¿ããããã«ããã®ãšã¹ãã«åã¯å¥œãŸããã¯
ïŒâ以äžã§ãããªãã äžèšãšãŒãã«åã¯ææž©äžã«äºæ¥µæ§éãããã³æº¶
åªäŸãã°ãžã¡ãã«ã¹ã«ããã·ããŸãã¯ã°ãªã³ãŒã«
ãžãšãŒãã«äžã§ãããªãã®ã奜ãŸãããå žåçãª
äºååçæ±æ žçœ®æåå¿ïŒSNïŒåå¿ïŒã«åŸã€ãŠç
ããããã®ã¿ã€ãã®åå¿ã¯äžå¿ççŽ ååäžã«ãã
ãç«äœé 眮ã®é転ãåžžã«äŒŽãªãããã®ç«äœé 眮ã
é転ïŒããã¯ãå転ããŸãã¯ãã¯ã«ãã³å転ããš
ãåŒã°ããŠããïŒããããšããã¢ã·ã«åºãïŒäœã§
ãšã³ãæ¹åã«ç«ã¡äžãã€ãŠããïŒïŒïŒïŒïŒïŒïŒâ
ãžã¢ã³ãããââã°ã«ãžããâïŒâã¢ã·ã«èªå°
äœãããæ°ãã«å°å ¥ãããããããšãã«ãšãŒãã«
åºããšã³ãäœã§ã¯ãªããšããœäœã«ç«ã¡äžãã€ããš
ãŒãã«åïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€
ãžããèªå°äœãåžžã«åŸãããçç±ã§ãããSNïŒ
åå¿ã«ãããŠã¯ãã®ããã«ã¯ã«ãã³å転ãçãã
ã®ã§ãçžå¿ããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã€ãžããã¢ã·ã«åç©ããïŒäœã«ãšã³ã眮æã
ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ã
ããšãŒãã«ãåŸãããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããââãã³ãããã¢ã·ã«åç©ããïŒäœã«ãšã
ãœçœ®æããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââ
ã°ã«ã·ãããšãŒãã«ãåŸãããïŒïŒïŒïŒïŒïŒïŒâ
ãžã¢ã³ãããââã°ã«ã·ããâïŒâãšããœâã¢
ã·ã¬ãŒãããïŒäœã«ãšã³ã眮æããïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããââãã³ããããšãŒãã«ãåŸ
ãããã®ã§ããã ãã®ç¬¬ïŒã®æ¹æ³ã«åŸããšãäžè¬åŒïŒïŒããã³
ïŒïŒã§ç€ºãããååç©ã§ãã€ãŠïŒ²ããã³ããã€
ã«åºã§ãããã®ã補é ã§ãããã®å Žåãã³ãã³é ž
æ®åºã¯çžå¿ããã€ãœãœã«ãããããã¯ã€ãœã€ãžã
ãã€ãã¬ãŒãã®ïŒïŒãšããœïŒäœãããã¯ïŒïŒãšã
ãœïŒäœãå ããããããååç©ã補é ããã«ã¯ã
ãšã³ãæ¹åã«ç«ã¡äžãã€ãã¡ã¿ã³ã¹ã«ããã«åºã
æããã€ãœããã·ãã¡ã¿ã³ã¹ã«ãããŒããææž©äž
ã«äºæ¥µæ§éãããã³æº¶åªäŸãã°ãžã¡ãã«ãã«ã ã¢
ããäžã§ãã³ãã³é žã®é©åœãªå¡©äŸãã°ãã³ãã³é ž
ãããªãŠã ã«ãã€ãŠSNïŒåå¿ã«äŸããããã®å Ž
åãã眮æäœã§ç«äœé 眮ã®é転ãçãããããã³
ãã³é žå¡©ã®æ±æ žåã¯ç«äœçã«ãã匷åºã«é害ãã
ãŠããã€ãœããã·ããšããœâã¡ã¿ã³ã¹ã«ãããŒã
ãã眮æããã«ã¯äžå åã§ããã ããããŠåŸãããã€ãœããã·ããã³ãããŒãã
æ¢è¿°ã®ããã«ç¡é žã§ãšã¹ãã«åããŠã€ãœããã·ã
ãã³ãããŒããã€ãã¬ãŒããåŸãããã®ããã«ã
ãŠãäŸãã°ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã°ã«ã·ããâïŒâã¡ã¿ã³ã¹ã«ãããŒãããžã¡ã
ã«ãã«ã ã¢ããäž150âã§ãã³ãã³é žãããªãŠã
ãšåå¿ãããŠïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã€ãžããâïŒâãã³ãããŒããåŸãããã€ãã§
ãããç¡é žã§ãšã¹ãã«åããŠææã®ïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããââã€ãžããâïŒâãã³ãã
ãŒãâïŒâãã€ãã¬ãŒããåŸãããã äžè¬åŒïŒïŒã§ç€ºãããååç©ã§ãã€ãŠïŒ²ãã
ã³ããã€ã«åºã§ãããã®ããã®ççåŠçã«èš±å®¹ã§
ããå¡©ã«è»¢åããããã«ã¯ãç¡æ©é žããã³é±é žäŸ
ãã°ããã²ã³åæ°ŽçŽ é žããã³ãªã³é žäžŠã³ã«ã«ã«ã
ã³é žãã¹ã«ãã³é žã®ãããªææ©é žäŸãã°ããã³
é žãã³ãã¯é žãä¹³é žãé ç³é žããªã³ãŽé žãå®æ¯éŠ
é žãã¯ãšã³é žãã¢ã¹ã³ã«ãã³é žãŸãã¯ïœâãã«ãš
ã³ã¹ã«ãã³é žãçšããããšãã§ããããã®é žä»å
å¡©ãå¡©åºäŸãã°çé žæ°ŽçŽ ãããªãŠã ãããã¯ã«ãª
ãŠã ã§æ³šææ·±ãåŠçãããšéé¢ã®å¡©åºãåã³åé¢
ãããã ãã®çºæã¯è¬å€çµæç©ã«ãä¿ããããã¯éåžžã®
æ äœããã³æ·»å å€ã«å ããŠãã®çºæã®ååç©ãŸã
ã¯ãã®ççåŠçã«èš±å®¹ã§ããå¡©ã®ãã¡ã®å°ãªããš
ãïŒçš®ãå«ãã§ããããã®çµæç©ã¯äººäœã«å¯Ÿãå»
è¬ãšããŠããã³ç£å»è¬ãšããŠçšããããšãã§ã
ããéåžžã®æ äœãšããŠã¯ãäŸãã°ãæ°Žãæ€ç©æ²¹ã
ããªãšãã¬ã³ã°ãªã³ãŒã«ãã°ãªã»ãªã³ãšã¹ãã«ã
ãŒã©ãã³ãçåæ°ŽçŽ äŸãã°ã©ã¯ããŒã¹ãŸãã¯ã¹ã¿
ãŒããã¹ãã¢ãªã³é žãã°ãã·ãŠã ãã¿ã«ã¯ãã¯ã»
ãªã³ããããéåžžã®æ·»å å€ãšããŠã¯ãäŸãã°ãé²
è å€ãå®å®å€ã最æ»å€ã湿最å€ãä¹³åå€ãççåŠ
çã«èš±å®¹ã§ããå¡©ãç·©è¡å€ãçè²å€ã颚å³å€ãéŠ
æããããæ äœããã³æ·»å å€ã¯ãã®çºæã®ååç©
ãçµè žãéçµå£ãå±æã®ãããã«ãã€ãŠæäžãã
ããã«ãã€ãŠéžæããã ãã®çºæã®ååç©ã¯ä»ã®æŽ»æ§ç©è³ªäŸãã°ãã¿ã
ã³é¡ãŸãã¯åžè²©ã®å¿åŸªç°å€ãšãšãã«ãããã«ç¹ã«
βâå容äœé»æ¢ç©ãšãšãã«æäžããããšãã§ã
ãã è¬å€çµæç©ã®äŸ åïŒmgã®æŽ»æ§ç©è³ªãå«æããå100mgã®é å€ã
補é ããããã«ã以äžã®ç©è³ªãå¿ èŠãšãããã ïŒïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°
ã«ã·ããâïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒ
ãïŒïŒïœïŒ ïŒïŒ 埮çµæ¶ã»ã«ããŒã¹ïŒ54ïœïŒ ïŒïŒ ã©ã¯ããŒã¹ïŒ20ïœïŒ ïŒïŒ ãšãããããã¹ã¿ãŒãïŒ20ïœïŒ ïŒïŒ ã³ãã€ãç¶ã±ã€é žïŒ0.5ïœïŒ ïŒïŒ ã¹ãã¢ãªã³é žãã°ãã·ãŠã ïŒ0.5ïœïŒ ïŒïŒãïŒïŒã®ç©è³ªã10åé也ç¥æ··åããã€
ãã§ãã®æ··åç©ãç©è³ªïŒïŒããã³ïŒïŒã«å
ããããã«10åéæ··åããåŸãããç²æ«ãé å€æ©
ã§ãã¬ã¹ããŠåã 100mgã®é å€ãåŸãã 以äžãå®æœäŸãèšããåå®æœäŸã§åŸãååç©ã
ãã³äžéäœã¯è¬å€çµæç©çšã«ç¹ã«å¥œé©ãªãã®ã§ã
ãã å®æœäŸäžã®åç¥å·ã¯æ¬¡ã®æå³ãè¡šããã m.p.âŠâŠèç¹ïŒéä¿®æ£ïŒ ïœâŠâŠå¯åºŠ ãαã25 DâŠâŠ25âã§ã®å åŠå転ããããªãŠã 
ç·å åŠå転å€ã®æ¬¡ã«ã枬å®ãã溶液ã®æ¿åºŠã瀺ã
ããŠãããäŸãã°ãc2ã¯æ¿åºŠïŒïœïŒ100ml溶液ã
æå³ãããããããã®æº¶åªã¯å¥ã ã«ç€ºããŠããã å®æœäŸ ïŒ ïŒââïŒïŒâã¯ããããšãã«ïŒâïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããââã€ãžããâïŒâãã€ã
ã¬ãŒãïŒ ïœ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ãããïŒâã¡ã¿ã³ã¹ã«ãããŒããïŒâã¡ã¿ã³ã¹
ã«ãããŒãããã³ïŒïŒïŒâãžã¡ã¿ã³ã¹ã«ãããŒ
ãïŒ ããªãžã³24äžã®ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããââã°ã«ã·ãã4.82KgïŒ33ã¢ã«ïŒæº¶æ¶²ã«
æ°Žåãæé€ããæ¹æããªããâ15âãâ20âã«
å·åŽãã€ã€æ°æéãããŠã¡ã¿ã³ã¹ã«ãã³é žã¯ã
ãªã3.1ïŒ40ã¢ã«ïŒã滎äžããããã®åŸå·åŽ
ããããšãªãããã«15æéæ¹æãããç空äžã§
ããªãžã³ãçå»ããæ²¹ç¶æ®æž£ãæ°Ž15ã«å ãã
沞隰ãããå·åŽãããåžåŒãéããæ°ŽïŒã§æŽ
æµããçµæ¶æ²ã§ãã也ç¥ããŠïŒïŒïŒïŒïŒïŒïŒâ
ãžã¢ã³ãããââã°ã«ã·ããâïŒïŒïŒâãžã¡
ã¿ã³ã¹ã«ãããŒã2.22KgïŒ7.34ã¢ã«ïŒãåŸãã
ã液ããæ¹æãæ°Žå·ããªããæ°Žé žåãããªãŠã
çŽ1.5Kgã§äžåããç空äžçŽ70âã§èžçºä¹Ÿåºã
ãã也ç¥æ®æž£ãå šéšã§30ã®ã¯ãããã«ã ã§é£
ç¶çã«ç±æœåºããæœåºç©ãç±éãéããããã®
æœåºç©ã20âã§15æéæŸçœ®ããçµæ¶æ²ã§ããåž
åŒãéããïŒã®ã¯ãããã«ã ã§ïŒåæŽæµãã
也ç¥ããŠïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââ
ã°ã«ã·ããâïŒâã¡ã¿ã³ã¹ã«ãããŒã2.3Kg
ïŒ10.26ã¢ã«ïŒãåŸããã液ãåãããŠç空äžã§
èžçºãããæ®æž£ããšã¿ããŒã«22ã«ç±é溶解ã
ããããã20âã§15æéæŸçœ®ããçµæ¶æ²ã¹ãã
åžåŒãéããïŒã®ãšã¿ããŒã«ã§ïŒåæŽæµãã
也ç¥ããŠïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââ
ã°ã«ã·ããâïŒâã¡ã¿ã³ã¹ã«ãããŒã0.65Kg
ïŒ2.90ã¢ã«ïŒãåŸããã液ãèžçºãããŠåŸïŒè
ã®ç°æ§äœã¢ãã¡ã¿ã³ã¹ã«ãããŒãæ··åç©2.21Kg
ïŒ9.85ã¢ã«ïŒãåŸããããã¯ã¯ãããã«ã ãã
ã®åçµããã³ãšã¿ããŒã«ããã®åçµã亀äºã«ã
ãããããããªãããšã«ãã€ãŠããã«åé¢ã§
ãããããã¯ããªãžã³äžã§ã¡ã¿ã³ã¹ã«ãã³é žã¯
ããªãã§ãšã¹ãã«åããããšã«ãã€ãŠïŒïŒïŒïŒ
ïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ããâïŒïŒ
ïŒâãžã¡ã¿ã³ã¹ã«ãããŒãã«å®å šã«è»¢åããã åçµæ¶åŸã®ã¡ã¿ã³ã¹ã«ãããŒãã®ç©æ§ã次衚
ã«ãŸãšããã ãè¡šã ãè¡šã ïœ ïŒâïŒïŒâã¯ããããšãã«ïŒâïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããââã€ãžããïŒ ç¡æ°Žãžã¡ãã«ã¹ã«ããã·ãïŒDMSOïŒ70ml
äžïŒâã¯ããããšããŒã«13.0ïœïŒ0.1ã¢ã«ïŒæº¶
液ã«æ°ŽçŽ åãããªãŠã 2.4ïœïŒ0.1ã¢ã«ïŒãåŸã
ã«å ãããæ¹æããæ°Žåãæé€ããŠ80âã«ç±
ããç¡æ°ŽDMSO30mläžïŒïŒïŒïŒïŒïŒïŒâãžã¢
ã³ãããââã°ã«ã·ããâïŒâã¡ã¿ã³ã¹ã«ã
ããŒã11.2ïœïŒ0.05ã¢ã«ïŒæº¶æ¶²ã滎äžããã80
âã§24æéæ¹æããåŸå·åŽããæªåå¿æ°ŽçŽ åã
ããªãŠã ãå æ°Žå解ããããã«æ°Žã滎äžããã€
ãã§æ°Ž100mlããã³ã¯ãããã«ã 200mlãå ã
ããå åã«æ¹æããã¯ãããã«ã çžãåé¢ãã
ãããæ°Ž200mlã1Mæ°Žé žåãããªãŠã 氎溶液
100mlããã³æ°Ž100mlã§é 次æ¯çªããç¡æ°Žç¡«é žã
ããªãŠã äžã§ä¹Ÿç¥ããç空äžã§èžçºããããªã€
ããæ®æž£ãã¯ãããã«ã ïŒãšã¿ããŒã«ããåçµ
æ¶ãããŠïŒâïŒïŒâã¯ããããšãã«ïŒâïŒïŒ
ïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžãã11.5
ïœïŒ45ããªã¢ã«ïŒãåŸããåæå€ã¯ä»¥äžã®ãšã
ãã§ãã€ãã m.p.107ã110âïŒãαã25 D17.0ïŒc2ïŒã¯ãããã«
ã ïŒ å çŽ åæ ïŒC12H13ClO4ïŒïŒ256.68ïŒïŒ ãè¡šã ïœ ïŒâïŒïŒâã¯ããããšãã«ïŒâïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããââã€ãžããâïŒâãã€ã
ã¬ãŒãïŒ é ¢é ž150mlããã³ç¡æ°Žé ¢é ž35mläžïŒââïŒïŒ
âã¯ããããšãã«ïŒâïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³
ãããââã€ãžãã13ïœïŒ50ããªã¢ã«ïŒæº¶æ¶²
ã«ãæ¹æã10âã«å·åŽããªããæ°·é ¢é ž50mlãã
ã³ç¡æ°Žé ¢é ž12.5mläž65ïŒ ç¡é ž3.5ml溶液ãïŒæ
éã§æ»ŽäžããåŸã ã«å®€æž©ãŸã§å æž©ããªããäžæ©
æ¹æãããã¯ãããã«ã ããã³æ°Žããããã
250mlãã€å ããæ¹æããã¯ãããã«ã çžãå
é¢ãããããæ°Ž250mlã§æŽæµãããç¡æ°Žç¡«é žã
ããªãŠã äžã§ä¹Ÿç¥ããåŸãæžå§äžã§èžçºãã
ããæ²¹ç¶æ®æž£ããšã¿ããŒã«ããåçµæ¶ãããŠïŒ
âïŒïŒâã¯ããããšãã«ïŒâïŒïŒïŒïŒïŒïŒïŒâ
ãžã¢ã³ãããââã€ãžããâïŒâãã€ãã¬ãŒ
ã13.3ïœïŒ44ããªã¢ã«ïŒãåŸããåæçµæã¯æ¬¡
ã®ãšããã§ãã€ãã m.p.76ã77âïŒãαã25 D41.4ïŒc2ïŒã¯ãããã«
ã ïŒ å çŽ åæ ïŒC12H12ClNO6ïŒïŒ301.63ïŒïŒ ãè¡šã å®æœäŸ ïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžãã
âïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒãïŒ ïœ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžã
ãâïŒâãã€ãã¬ãŒãïŒ é ¢é ž800mlããã³ç¡æ°Žé ¢é ž280mläžïŒïŒïŒïŒ
ïŒïŒïŒâãžã¢ã³ãããââã€ãžãã62ïœ
ïŒ0.42ã¢ã«ïŒæº¶æ¶²ã«ãæ¹æããïŒã10âã«å·åŽ
ããªããã95ïŒ ç¡é žïŒå¯åºŠ1.5ïŒ18.5ïœïŒ0.42ã¢
ã«ïŒãé ¢é ž400mlããã³ç¡æ°Žé ¢é ž100mlãããªã
æ··åç©ã滎äžãã12æéæ¹æããããããæ°Ž
3.5ã§åžéããçé žæ°ŽçŽ ãããªãŠã ãåŸã ã«
å ããŠäžåããã¯ãããã«ã 1000mlã§ïŒåæœåº
ããã¯ãããã«ã æœåºæ¶²ãèžçºãããç¡æ°Žç¡«é ž
ãããªãŠã äžã§ä¹Ÿç¥ããæžå§äžã§ã»ãŒä¹Ÿåºãã
ããããããŠåŸãã¢ããã€ãã¬ãŒããšãžãã€ã
ã¬ãŒãã®æ··åç©ããšãŒãã«250mlã«æº¶è§£ããæ°Ž
100mlã§10åæœåºãããæ°Žçžã¯ã¢ããã€ãã¬ãŒ
ãïŒRfïŒ0.47ïŒã·ãªã«ã²ã«ä»äžããã¬ãŒããã¯
ãããã«ã ïŒã¡ã¿ããŒã«ïŒïŒïŒïŒïŒãå«æããŠ
ããããžãã€ãã¬ãŒãïŒRfïŒ0.75ïŒã¯ãšãŒãã«
çžäžã«æ®ã€ããæ°Žçžãå¡©åãããªãŠã ã§é£œå
ããã¯ãããã«ã 200mlã§ïŒåæœåºããæžå§äž
ã§ã¯ãããã«ã æœåºæ¶²ãèžçºãããŠç¡è²æ²¹ã®åœ¢
æ ã«ããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââ
ã€ãžããâïŒâãã€ãã¬ãŒã32.1ïœïŒ0.17ã¢
ã«ïŒãåŸããããã¯ããã«ç²Ÿè£œããããšãªã以
åŸã®ãšã¹ãã«åã«çšããã ïœ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžã
ãâïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒãïŒ ç¡æ°Žããªãžã³150mlãïŒïŒïŒïŒïŒïŒïŒâãžã¢
ã³ãããââã€ãžããâïŒâãã€ãã¬ãŒã
9.5ïœïŒ50ããªã¢ã«ïŒããã³ãã³ãã³é žã¯ããª
ã7.7ïœïŒ55ããªã¢ã«ïŒãããªãæ··åç©ãæ°Žå
ãæé€ããŠ20â24æéæ¹æãããæžå§ïŒ10ããª
ããŒã«ïŒäžã§ããªãžã³ãèžçºãããæ®æž£ãçé ž
æ°ŽçŽ ãããªãŠã 氎溶液ã§äžåããæžå§äžã§åã³
èžçºãããæ®æž£ã沞隰ã¯ãããã«ã ã§æœåºã
ããã¯ãããã«ã æœåºæ¶²ãèžçºããç¡æ°Žç¡«é žã
ããªãŠã äžã§ä¹Ÿç¥ããã¡ã¿ããŒã«ããåçµæ¶ã
ããŠïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãž
ããâïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒã
11.8ïœïŒ40ããªã¢ã«ïŒãåŸããåæçµæã¯æ¬¡ã®
ãšããã§ãã€ãã m.p.81ã83âïŒãαã25 D111ïŒc2ïŒã¯ãããã«
ã ïŒ å çŽ åæ ïŒC12H12N2O7ïŒïŒ296.24ïŒïŒ ãè¡šã å®æœäŸ ïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžãã
âïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒãïŒ ïœ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžã
ãâïŒâãã³ãããŒãïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâã¡ã¿ã³ã¹ã«ãããŒãïŒå®æœäŸ1aïŒ
ã«åŸã€ãŠè£œé ïŒ45ïœïŒ0.2ã¢ã«ïŒããã³ãã³é žã
ããªãŠã 32ïœïŒ0.22ã¢ã«ïŒããã³ç¡æ°Žãžã¡ãã«
ãã«ãã¢ãã500mlãããªãæ··åç©ã150âã§15
æéæ¹æããã溶åªãçå»ããæ®æž£ãæ°Ž200ml
ã«æº¶è§£ãã掻æ§çïŒïœãå ãããéãããã液
ãåžæ°Žé žåãããªãŠã 氎溶液ã§PHïŒãïŒã«èª¿ç¯
ããã¯ãããã«ã 200mlã§ïŒåæœåºãããã¯ã
ããã«ã æœåºæ¶²ãåããã0.25Må¡©é ž200mlã§
ïŒåæœåºããå¡©é žæœåºæ¶²ãåãããã¯ãããã«
ã 200mlã§æŽæµããæžå§äžã§èžçºãããšã¿ããŒ
ã«ïŒã¯ãããã«ã ã§å ±æ²žä¹Ÿç¥ãããæ®æž£ããšã¿
ããŒã«ïŒã€ãœãããããŒã«ããåçµæ¶ãããŠ
ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžãã
âïŒâãã€ãã¬ãŒããããã¯ããªãçµæ¶17.4ïœ
ïŒ60.6ããªã¢ã«ïŒãåŸããåæçµæã¯æ¬¡ã®ãšã
ãã§ãã€ãã m.p.148ã150âïŒãαã25 D52.6ïŒc10ïŒæ°ŽïŒïŒ å çŽ åæ ïŒC12H13NO5ã»xHClïŒïŒ287.70ïŒ ãè¡šã ïœ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžã
ãâïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒãïŒ 95ïŒ ç¡é ž50mläžå°¿çŽ 3.5ïœïŒ58ããªã¢ã«ïŒæº¶
液ã«ãæ¹æããâ20âã«å·åŽãã€ã€ãã¡ã¿ã³ã¹
ã«ãã³é ž30mläžïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ããã
ââã€ãžããâïŒâãã³ãããŒãïŒäžèšïœïŒ
ã§åŸãããã¯ããªãã®éé¢å¡©åºïŒ14ïœïŒ56ããª
ã¢ã«ïŒã滎äžããâ20âã§ïŒæéæ¹æããæ°·æ°Ž
200mlã«æ³šäžããå·åŽãã€ã€ãæ°Ž200mlã«æº¶è§£ã
ãæ°Žé žåãããªãŠã 65ïœã滎äžãããçé žæ°ŽçŽ
ãããªãŠã ãå ããŠäžåãå®çµãããã¯ããã
ã«ã 100mlã§ïŒåæœåºãããæœåºæ¶²ãåããã
æ°Ž100mlã§æŽæµããç¡æ°Žç¡«é žãããªãŠã äžã§ä¹Ÿ
ç¥ããæžå§äžã§èžçºããŠç¡è²ã§ãã€ãããšåºå
ããæ²¹ã®åœ¢æ ã«ããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããââã€ãžããâïŒâãã€ãã¬ãŒãâïŒâ
ãã³ãããŒã10.8ïœïŒ36.5ããªã¢ã«ïŒãåŸãã
ãããã¯ãããã«ã ã«æº¶è§£ããå¡©é žäžã«éããŠ
ãšãŒãã«ã§ãããã¯ããªããæåºãããã€ãœã
ããããŒã«ïŒãšãŒãã«ããåçµæ¶ãããã m.p.151ã152âïŒå解ïŒïŒãαã25 D77.2ïŒc0.5ïŒ
ãšã¿ããŒã«ïŒ å çŽ åæ ïŒC12H12N2O7ã»xHClïŒ
ïŒ332.69ïŒïŒ ãè¡šã å®æœäŸ ïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ã
ãâïŒâãã€ãã¬ãŒãâïŒâã¡ã¿ã³ã¹ã«ãããŒ
ãïŒ é ¢é ž200mlããã³ç¡æ°Žé ¢é ž75mläžïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããââã°ã«ã·ããâïŒâã¡ã¿ã³
ã¹ã«ãããŒãïŒå®æœäŸ1aïŒã«åŸã€ãŠè£œé ïŒ22.4ïœ
ïŒ100ããªã¢ã«ïŒæº¶æ¶²ã«ãæ¹æã10âã«å·åŽãã€
ã€ãé ¢é ž100mlããã³ç¡æ°Žé ¢é ž25mläž95ïŒ ç¡é ž4.5
mlïŒ100ããªã¢ã«ïŒæº¶æ¶²ã滎äžããåŸã ã«å®€æž©ã«
å æž©ããªããïŒæéæ¹æããæ°Ž1200mlãå ããç
é žæ°ŽçŽ ãããªãŠã ã§å°ãã¥ã€äžåããã¯ãããã«
ã 300mlã§ïŒåæœåºãããã¯ãããã«ã æœåºæ¶²ã
ç¡æ°Žç¡«é žãããªãŠã äžã§ä¹Ÿç¥ããæžå§äžã§èžçºã
ããã¯ãããã«ã ïŒãšãŒãã«ããåçµæ¶ãããŠ
ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ãã
âïŒâãã€ãã¬ãŒãâïŒâã¡ã¿ã³ã¹ã«ãããŒã
22.6ïœïŒ84ããªã¢ã«ïŒãåŸãã m.p.105ã106âïŒãαã25 D91ïŒc2.0ïŒã¯ãããã«
ã ïŒ å çŽ åæ ïŒC7H11NO8SïŒïŒ269.24ïŒïŒ ãè¡šã å®æœäŸ ïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ã
ãâïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒãïŒ ïœ ç¡é žã«ããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã°ã«ã·ããã®ãšã¹ãã«åïŒ ç¡æ°Žããªãžã³1500mläžïŒïŒïŒïŒïŒïŒïŒâãžã¢
ã³ãããââã°ã«ã·ãã73ïœïŒ500ããªã¢ã«ïŒ
溶液ããæ¹æãæ°Žåãæé€ãã10âã«å·åŽãã€
ã€ãå šéšã§72ïœïŒ500ããªã¢ã«ïŒã®ãã³ãã³é ž
ã¯ããªããšåŸã ã«æ··åããè©²é žã¯ããªãã®åå¿
ãå®çµãããŸã§ïŒçŽïŒæéïŒ50ã60âã§æ¹æã
ããæžå§äžã§ããªãžã³ãçå»ããæ®æž£ãçé žæ°Ž
çŽ ãããªãŠã 氎溶液ã§PHïŒã«èª¿ç¯ããæžå§äžã§
åã³èžçºãããæ®æž£ã沞隰ã¯ãããã«ã 400ml
ã§ïŒåæœåºãããã¯ãããã«ã æœåºæ¶²ãåãã
500mlã«æ¿çž®ããæ°ŽïŒïŒïŒïŒ ãšã¿ããŒã«ïŒã移
åäžå±€ãšããŠçšãã40段ã®ã¯ã¬ã€ã°åæµåé æ³
ã«äŸãããåãã©ã¯ã·ãšã³ãèå±€ã¯ãããã°ã©
ãæ³ïŒã·ãªã«ã²ã«F254ä»äžããã¬ãŒããã¯ã
ããã«ã ïŒã¡ã¿ããŒã«ïŒ9/1ïŒã§åé¢ãããã®
åæåã«åŸã€ãŠäžç·ã«ããèžçºãããã以äžã«
瀺ãåãã©ã¯ã·ãšã³ããããããã®ååç©ãåŸ
ãã ãã©ã¯ã·ãšã³ïŒãïŒããïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒïŒïŒâãžãã³ãããŒãïŒRfïŒ0.49ïŒ
48.5ïœïŒ136ããªã¢ã«ïŒãã¯ãããã«ã ïŒãšãŒã
ã«ããã®åçµæ¶åŸã®m.pïŒ142ã144âïŒæç®å€
ïŒè±åœç¹èš±ç¬¬1027891å·ïŒ143.5ã144âïŒããαã
25 D30.0ïŒc2.0ãã¯ãããã«ã ïŒïŒæç®å€ïŒ28.8ïŒ
ã¯ãããã«ã ïŒãå çŽ åæïŒC18H16N2O6ïŒ
ïŒ356.34ïŒïŒ ãè¡šã ãã©ã¯ã·ãšã³ïŒã14ããïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâãã³ãããŒãïŒRfïŒ0.32ïŒ18.6ïœ
ïŒ74ããªã¢ã«ïŒãã¯ãããã«ã ïŒç³æ²¹ãšãŒãã«ã
ãåçµæ¶åŸã®m.pïŒ112ã113.5âããαã25 D69.8
ïŒc2.0ïŒã¯ãããã«ã ïŒãå çŽ åæ
ïŒC12H13NO5ïŒïŒ251.24ïŒïŒ ãè¡šã ãã©ã¯ã·ãšã³15ã19ããïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâããã³ïŒâãã³ãããŒãæ··åç©4.5
ïœïŒ18ããªã¢ã«ïŒã ãã©ã¯ã·ãšã³20ã36ããïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâãã³ãããŒãïŒRfïŒ0.25ïŒ30.6ïœ
ïŒ122ããªã¢ã«ïŒãã¯ãããã«ã ïŒãšãŒãã«ãã
åçµæ¶åŸã®m.p.ïŒ84ã85.5âããαã25 D55.4
ïŒc2.0ïŒã¯ãããã«ã ïŒãå çŽ åæ
ïŒC12H13NO5ïŒïŒ251.24ïŒïŒ ãè¡šã ãªãããã©ã¯ã·ãšã³37ã40ã¯æªåå¿ã®ïŒïŒ
ïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ããã
å«ãã§ããã ïœ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒãïŒ é ¢é ž300mlããã³ç¡æ°Žé ¢é ž70mläžïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããââã°ã«ã·ããâïŒâãã³
ãããŒã25ïœïŒ100ããªã¢ã«ïŒæº¶æ¶²ã«ãæ¹æã
10âã«å·åŽãã€ã€ãé ¢é ž100mläž95ïŒ ç¡é ž6.6ml
ïŒ150ããªã¢ã«ïŒæº¶æ¶²ãåŸåŸã«æ»Žäžããããã«å
枩床ã§ïŒæéæ¹æããããããæ°Ž1500mlã§åžé
ããçé žæ°ŽçŽ ãããªãŠã ãå°ãã¥ã€å ããŠäžå
ããé ¢é žãšãã«500mlã§ïŒåæœåºãããæœåºæ¶²
ãåããçé žæ°ŽçŽ ãããªãŠã 氎溶液ã§æŽæµãã
ç¡æ°Žç¡«é žãããªãŠã äžã§ä¹Ÿç¥ããæžå§äžã§èžçº
ãããã¡ã¿ããŒã«ïŒæ°Žããåçµæ¶ãããŠïŒïŒ
ïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ããâ
ïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒã23.7ïœ
ïŒ80ããªã¢ã«ïŒãåŸãã m.pïŒ107ã108.5âïŒãαã25 D58.0ïŒc2.0ïŒã¯ã
ããã«ã ïŒ å çŽ åæ ïŒC12H12N2O7ïŒïŒ296.24ïŒ ãè¡šã å®æœäŸ ïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ã
ãâïŒâãã³ãããŒãâïŒâãã€ãã¬ãŒãïŒ å®æœäŸ5aïŒã§åŸãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããââã°ã«ã·ããâïŒâãã³ãããŒã12.5ïœ
ïŒ50ããªã¢ã«ïŒãç¡é žïŒç¡æ°Žé ¢é žïŒé ¢é žãšåå¿ã
ããã¯ãããã«ã ïŒãšãŒãã«ããåçµæ¶ãããŠ
ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ãã
âïŒâãã³ãããŒãâïŒâãã€ãã¬ãŒã10.7ïœ
ïŒ36ããªã¢ã«ïŒãåŸãã m.p.ïŒ54ã57âïŒãαã25 D117.2ïŒc2.0ïŒã¯ããã
ã«ã ïŒ å çŽ åæ ïŒC12H12N2O7ïŒïŒ296.24ïŒïŒ ãè¡šã å®æœäŸ ïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ã
ãâïŒâãã³ãããŒãâïŒâãã€ãã¬ãŒãïŒ ïœ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâããã³ïŒâãã€ãã¬ãŒãïŒ é ¢é ž300mlããã³ïŒç¡æ°Žé ¢é ž70mläžïŒïŒïŒïŒ
ïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ãã30ïœ
ïŒ200ããªã¢ã«ïŒæº¶æ¶²ã«ãæ¹æããïŒâã«å·åŽã
ã€ã€ãé ¢é ž50mläž65ïŒ ç¡é žïŒmlïŒ100ããªã¢ã«ïŒ
溶液ã滎äžããïŒæéæ¹æããããããæ°Ž1000
mlã§åžéããé ¢é žãšãã«500ã§ïŒåæœåºããã
æœåºæ¶²ãåãããæ¹æããªããçé žæ°ŽçŽ ãããª
ãŠã 氎溶液ãå°ãã¥ã€å ããŠäžåãããé ¢é žãš
ãã«çžãåé¢ããç¡æ°Žç¡«é žãããªãŠã äžã§ä¹Ÿç¥
ããæžå§äžã§çŽ50mlãŸã§æ¿çž®ããããã®æ¿çž®ç©
ããæµåºæ¶²ãšããŠãã«ãšã³ïŒé ¢é žãšãã«ïŒ1/1ïŒ
ãçšãã·ãªã«ã²ã«ïŒKgã§ã«ã©ã ã¯ãããã°ã©ã
æ³ã«ããåé¢ããã RfïŒ0.26ïŒã·ãªã«ã²ã«F254ä»äžããã¬ãŒãã
ãã«ãšã³ïŒé ¢é žãšãã«ïŒ1/1ïŒã®ãã©ã¯ã·ãšã³
ãæžå§äžã§èžçºããããšãŒãã«ããåçµæ¶ãã
ãŠïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâãã€ãã¬ãŒã2.6ïœïŒ13.6ããªã¢ã«ïŒ
ãåŸãã m.p.ïŒ53ã55.5âïŒæç®ïŒL.D.ãã€ã¯ãŒãä»
Can.J.Chem.ïŒ45ïŒ2191ãïŒïŒ1967ïŒå€52ã
53âïŒãαã25 D76.4ïŒc2.0ïŒã¯ãããã«ã ïŒãå
çŽ åæïŒC6H9NO6ïŒïŒ191.15ïŒïŒ ãè¡šã RfïŒ0.20ã®ãã©ã¯ã·ãšã³ãæžå§äžã§èžçºã
ããé ¢é žãšãã«ïŒç³æ²¹ãšãŒãã«ããåçµæ¶ãã
ãŠïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâãã€ãã¬ãŒã8.8ïœïŒ46ããªã¢ã«ïŒ
ãåŸãã m.p.86ã88âïŒæç®å€89.5ã91âïŒïŒãαã25 D
163.4ïŒc2.0ïŒã¯ãããã«ã ïŒ å çŽ åæ ïŒC6H9NO6ïŒïŒ191.15ïŒ ãè¡šã ïœ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâãã³ãããŒãâïŒâãã€ãã¬ãŒãïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâãã€ãã¬ãŒããå®æœäŸ2bïŒãšåæ§
ã®ææ³ã§ããªãžã³äžã§ãã³ãã³é žã¯ããªããšå
å¿ãããã¯ãããã«ã ïŒãšãŒãã«ããåçµæ¶ã
ããŠïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«
ã·ããâïŒâãã³ãããŒãâïŒâãã€ãã¬ãŒã
9.0ïœïŒ30.4ããªã¢ã«ïŒãåŸãã m.p.ïŒ55ã57â ãαã25 D117ïŒc2ïŒã¯ãããã«ã ïŒ å®æœäŸ ïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââãã³ãã
ãâïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒãïŒ é ¢é ž100mläžïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âãã³ãããâïŒâãã³ãããŒã10.3ïœïŒ41ã
ãªã¢ã«ïŒæº¶æ¶²ã«ç¡æ°Žé ¢é ž20mlããã³å°¿çŽ 0.6ïœã
å ããæ¹æã10âã«å·åŽãã€ã€ãé ¢é ž20mläž96ïŒ
ç¡é ž8.8ïœïŒ200ããªã¢ã«ïŒã滎äžãã宀枩ã§äžæ©
æ¹æãããã€ãã§ããããæ¹æããªããæ°·æ°Ž500
mlã«æ³šäžãã0.5æéæ¹æããå·åŽããªãã20ïŒ
æ°Žé žåãããªãŠã 氎溶液500mlãã€ãã§çé žæ°ŽçŽ
ãããªãŠã ãå ããŠäžåãããæ²ã§ãçæç©ãã¯
ãããã«ã ãå ããããšã«ãã€ãŠæº¶æ¶²ãšãããã
ã®æ··åç©ãã¯ãããã«ã 200mlã§ïŒåæœåºããã
æœåºæ¶²ãåãããæ°Ž200mlã§æŽæµããç¡æ°Žç¡«é žã
ããªãŠã äžã§ä¹Ÿç¥ããæžå§äžã§èžçºãããŠæ²¹ç¶ç²
çæç©ãåŸããããã€ãœãããããŒã«ãããã€ã
ã§ãšã¿ããŒã«ããåçµæ¶ãããŠç²Ÿè£œããïŒïŒïŒïŒ
ïŒïŒïŒâãžã¢ã³ãããââãã³ãããâïŒâã
ã€ãã¬ãŒãâïŒâãã³ãããŒã10.3ïœïŒ34.8ããª
ã¢ã«ïŒãåŸãã m.p.ïŒ132ã134â ãαã25 D264.3ïŒc0.5ïŒã¯ãããã«ã ïŒ å çŽ åæïŒC12H12N2O7ïŒïŒ296.24ïŒïŒ ãè¡šã ãã®çºæã®ååç©ã®è¬çåŠçæ§è³ªã調ã¹ãã«åœ
ããå¯Ÿç §ååç©ãšããŠåžè²©ã®ã€ãœãœã«ãããžãã€
ãã¬ãŒãïŒISDNïŒãããã³ã€ãœãœã«ããã¢ãã
ã€ãã¬ãŒãïŒISMNïŒïŒïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³
ãããââã°ã«ã·ããâïŒâãã€ãã¬ãŒãïŒã
åžžã«çšããã å åè貫æµå¢å€§å¹æã¯æåºãããã¢ã«ã¢ããã®
å¿èïŒã©ã³ã²ã³ãã«ãã«åŸãæåºå¿èããã³ã¬ãŒ
ä»Pflušger's ArchivïŒ353ïŒ317ã325ïŒ1975ïŒã«åŸ
ãæ¹æ³ïŒã«ã€ããŠèª¿ã¹ãã30ååŸã«å®åžžç¶æ ã«ãª
ã€ãŠãããåå¿èã«ãããã25ÎŒïœïŒmlã®è©Šéšå
åç©ãå«æããã¿ã€ããŒã液å50mlãæ³šå ¥ããã
åè©Šéšååç©ã¯ïŒåãïŒåã®å¿èã«ã€ããŠè©Šéšã
ãã ããããã®å Žåã«ã€ããŠãå€åæ§ã貫æµå¢å€§æ§
ããã³å¿æã調ã¹ããè¡šã«ç€ºãå€ã¯åæå€ã«å¯Ÿ
ããå¹³åå€åçïŒïŒ ïŒã§ããã è¡šã«ç€ºã枬å®å€ãæ¯èŒãããšããã®çºæã®å
åç©ã®å åè貫æµå¢å€§å¹æã¯ISMNããã倧ãã
ããšããããããã®çºæã®ååç©ã®ããã€ãã¯å¥œ
ãŸããå€åæ§ããã³å¿æäœäžäœçšã瀺ããŠããã ãè¡šã ãã«ã¢ãã¬ããªã³èªèµ·åçž®ããã³å¡©åã«ãªãŠã
èªèµ·åçž®ã®çããæåºããã©ãã倧åèã«ã€ããŠ
éçå¹æã調ã¹ãïŒãŠãšã³ãããã³ãã€ããŒã
Pflušnger's ArchivïŒ320ïŒ1970ïŒ133ã141ã«åŸã
æ¹æ³ïŒããã³ã¹ãããã«ãNaunynâScmiede
berg's Archiv of PharmacologyïŒSuppl.Vol.
308ïŒ1979ïŒR18ïŒãããã§ãå¯Ÿç §ååç©ãšããŠ
ISDNããã³ISMNãéžãã ã è¡šäžã«ã¯ççž®ã50ïŒ æå¶ããã«å¿ èŠãªè©Šéšå
åç©ã®ã¢ã«æ¿åºŠïŒED50å€ïŒã瀺ããŠããããã®
çºæã®ååç©ã®éçå¹æã¯ISMNãããè¯å¥œã§ã
ãŸãããã€ãã¯ISDNãããè¯å¥œã§ããã ãè¡šã è管å æäžã«ãã麻é åã¢ã«ã¢ããã«ã€ããŠã
ã®çºæã®ååç©ã®è¡å§éäžæ§ãISDNããã³
ISMNãšãšãã«èª¿ã¹ããè¡šã«ç€ºããå€ã¯ãã®çº
æã®ååç©ã¯ãã®ã»ãšãã©ãISMNããå¹æçã§
ãããå®æœäŸ2b ããã³5b ã®ååç©ãISDNãš
é¡äŒŒããŠããããšã瀺ããŠããã ãè¡šã ãè¡šã å®æœäŸ5bïŒã®ååç©ã®å€åæ§ããã³å¿ææ°äœ
äžå¹æãåäºæè žå æäžã«ãã€ãŠäœé2.5ã3.5Kg
ã®ã¢ã³ã°ã¬ã«ç«ã«ã€ããŠããã«èª¿ã¹ããç«ã¯ã¯ã
ã©ããŒã¹âãŠã¬ã¿ã³æ··åç©ïŒãŠã¬ã¿ã³1.2ïœïŒKg
ïŒã¯ãã©ããŒã¹40mgïŒKgè ¹è å æäžïŒã§éº»é åã
ãããã®ç«ã¯æ°ç®¡ã«ããŠãŒã¬ãéããŠèªç¶åŒåžã
ããå·Šå¿å®€ã«ã«ããŒãã«ãããããã¡ãŒã¿ãèšçœ®
ããããã«é åèãçšãããæ³šå ¥ã®ç®çã«é éè
ãçšãããå€§è ¿åèãä»ããŠã«ããŒãã«ãäžè¡å€§
åèäžã«æ¿å ¥ããè¡å§èšé²èšïŒStatham P23DbïŒ
ã«æ¥ç¶ãããå¿ææ°ããã«ã¹åšæ³¢æ°æž¬å®è£ 眮ïŒã
ãŠãŒãŽã»ã¶ãã¯ã¹ã»ãšã¬ã¯ããããã¯ç€Ÿè£œïŒã§å·Š
å¿å®€å§ä¿¡å·ããèšé²ãããåäºæè žã«ãŒããéè ¹
è¡ã«ããé²åºãããè©Šéšååç©ã¯çŽæ¥ç®¡å£ã«æ³šå ¥
ããã è¡šã«ç€ºãå€ããããã®çºæã®ååç©ã®è¡å§é
äžäœçšã¯ISDNãããè¯å¥œã§ããããšããããã ãè¡šã å¹³åå€ïŒæšæºèª€å·®ïŒïŒå¹ã®ç«çŸ€ïŒ
ãã®çºæã®ååç©ã®ããã€ãã«ã€ããŠæ¥æ§æ¯æ§
ã調ã¹ãããã«ãåååç©ãççé£å¡©æ°Žäžã§å¡©é ž
å¡©ã®åœ¢æ ã§éã®NMRIâã¢ã«ããããŠã¹ã«ãã
ãã100mlïŒKgããã³200mgïŒKgã®å²åã§éèå æ
äžãããåååç©ã¯äžæäžåœãå°ãªããšãäžå¹ã«
察ããŠæ³šå ¥ãããæ倧éæäžåŸã§ãæ»äº¡ããªãã€
ãå Žåã¯ãã以äžã®æäžã¯ãããªããªãã€ããç
åãçããå Žåã«ã¯ãåäžæäžéããã€ãŠããã«
å°ãªããšãïŒå¹ã«ã€ããŠå®éšãããè¿ãããæäž
åŸ24æé以å ã®æ»äº¡çã芳å¯ããã è¡šã«ã枬å®ããæ»äº¡çããã³ããããèšç®ã
ãLD50ç¯å²ã瀺ãã ãè¡šã
ã³ã¹ã«ããã«åºãŸãã¯ãã³ããã€ã«åºïŒã§ç€ºãã
ãïŒâããã³ïŒâ眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢
ã³ãããããã·ããã¢ããã€ãã¬ãŒãååç©äžŠã³
ã«ïŒ²ããã³ããã€ã«åºã«ããããã®ççåŠçã«èš±
容ã§ããé žä»å å¡©ã«é¢ããã ãããååç©ã®åºæ¬æ§é ã¯ãšãåã«ãã€ãŠçžäº
ã«è»¢åãåŸãç«äœç°æ§ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããããã·ãããããªãã¡åŒ ã§ç€ºãããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââ
ã€ãžããïŒã€ãœã€ãžãïŒïŒããã§ã¯ãïŒäœããã³
ïŒäœã®åOHåºã¯ãšããœåœ¢ããšã€ãŠããïŒããã³
åŒ ã§ç€ºãããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââ
ã°ã«ã·ããïŒã€ãœãœã«ããïŒïŒããã¯ãïŒäœã«ãš
ããœæ¹åã«ç«ã¡äžãã€ãOHåºããã³ïŒäœã«ãšã³
ãæ¹åã«ç«ã¡äžãã€ãOHåºãæã€ãŠããããã
ãã€ãŠãïŒäœããã³ïŒäœã«ç°ãªã眮æåºãååšã
ãå ŽåïŒã€ã®ç°æ§äœãååšãããïŒã®ããããäž
æ¹ãããªãã ãŸããããã€ãã®ååç©ã®åºæ¬æ§é ã¯åŒ ã§ç€ºãããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââ
ãã³ãããïŒã€ãœãã³ããïŒãããªããããã¯ãš
ã³ãæ¹åã«ç«ã¡äžãã€ãïŒã€ã®OHåºãæã€ãŠã
ãã ã°ã«ã·ããèªå°äœãšå¯Ÿæ¯ããŠã¿ããšã€ãžããã
ãã³ãã³ãããèªå°äœã®å Žåã¯ãïŒäœããã³ïŒäœ
ã®çœ®æåºã®éã«ã¯å·®ã¯ãªããïŒäœã®ïŒ£ååã¯åå
ã180ãå転ãããããšã«ãã€ãŠïŒäœã®ïŒ£ååãšãª
ãããã§ããããããèªå°äœã®å Žåã«ã¯çœ®æåºã«
ã€ããŠïŒäœãšãïŒäœãšãããå¿ èŠã¯ãªããããã
ãªãããåã ã®ååç©ã®æ§é ãäžè¬åŒãšãããã
察æ¯ãããããã«ãã€ãœã€ãžãèªå°äœããã®æ现
æžã§ã¯ïŒâäœçœ®æã€ãœã€ãžãèªå°äœãšåŒã¶ããš
ãšããããããã¯ç«äœé 眮ã®é転ã䌎ãªã€ãŠèŠªæ ž
眮æåå¿ã«ãã€ãŠäŸãã°ïŒââã¢ã«ãã«ã¹ã«ã
ãã«ã€ãœãœã«ãããŸãã¯ïŒâã¢ãªãŒã«ã¹ã«ãã
ã«ã€ãœãœã«ããããåŸãããšãã§ããããã§ã
ãã ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããããã·ããã®ç«
äœç°æ§ã«ã€ããŠã®ç°¡åãªæŠèŠãJ.A.ãã«ãº
ïŒMillsïŒã«ãã€ãŠã¢ãããŒã³ã·ãºã»ã€ã³ã»ã«ãŒã
ãã€ãã¬ãŒãã»ã±ãã¹ããªãŒã10 ïŒã53ïŒ1955ïŒ
ã«ç€ºãããŠããã ãã®çºæã¯åãã«è¿°ã¹ãïŒâããã³ïŒâ眮
æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããããã·ããã¢ã
ãã€ãã¬ãŒãã®è£œé æ¹æ³ããã³è¬å€çµæç©ã«ãé¢
ãããã®ã§ããã ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ã
ãïŒïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââãœã«ã
ãããšãåŒã°ããïŒã®ãã€ãã¬ãŒãïŒããªãã¡ïŒ
âã¢ããã€ãã¬ãŒãããã³ïŒâã¢ããã€ãã¬ãŒã
ã°ããã§ãªãïŒïŒïŒâãžãã€ãã¬ãŒããïŒã¯äŸã
ã°ç±³åœç¹èš±ç¬¬3886186å·ã«èšèŒãããŠããããã
ããã€ãã¬ãŒããç¹ã«ãžãã€ãã¬ãŒãïŒããã¯è¬
å€ãšããŠåžè²©ãããŠããïŒã¯è¡è¡ååŠçãè¡ç®¡æ¡
匵æ§ããã³æçå¿çæ§å¹æãæããè¬çåŠç掻æ§
ç©è³ªã§ãããç¹ã«å ç¶åèäžå šãçå¿çã®æ²»çã«
çšããããŠããã ããã«ãç±³åœç¹èš±ç¬¬3886186å·ã«ã¯ãã€ãœãœã«
ããã®ïŒâã¢ã»ããŒãâïŒâãã€ãã¬ãŒããïŒâ
ã¢ã»ããŒãâïŒâãã€ãã¬ãŒããïŒâãšãã¬ãŒã
âïŒâãã€ãã¬ãŒããïŒâãã€ãã¬ãŒãâïŒâã¹
ã«ãã¢ã¡ãŒããïŒâã«ã«ãã¡ãŒãâïŒâãã€ãã¬
ãŒãããã³ïŒâã«ã«ãã¡ãŒãâïŒâãã€ãã¬ãŒ
ããããã«ã¯çžå¿ããããããªããŒããããã¬ãŒ
ããã€ãœããã¬ãŒããã«ãããšãŒãããã³ãã³ãŸ
ãšãŒãã¢ããã€ãã¬ãŒãã瀺ãããŠããã ããã«ãŸããã€ãœã€ãžããã€ãœãœã«ããããã³
ã€ãœãã³ããã®ã¢ããã€ãã¬ãŒãã®ïœâãã«ãšã³
ã¹ã«ãã³é žãšã¹ãã«ãç¥ãããŠããïŒCan.J.
Chem.ïŒ45ïŒ2191ã2194ïŒ1967ïŒåç §ãããããª
ããããããååç©ã®èµ€å€ç·åžåã¹ãã¯ãã«ã ã
ã詳ããèšãããŠããã ãã§ããããããååç©
ã®è¬çåŠçæ§è³ªã«ã€ããŠã¯äœãç¥ãããŠããªãã ã€ãœãœã«ãããã€ãœãã³ããããã³ã€ãœã€ãžã
ã®ãžãã€ãã¬ãŒãããã³ã¢ããã€ãã¬ãŒãã®åæ
è¬çåŠã«ã€ããŠã¯ãã¬ãšã«ãããã³ããã»ã«ã«ã
ã€ãŠNaunynâSchmiedeberg's Arch.
Pharmacol.ïŒ275ïŒ339ïŒ1972ïŒã«èšèŒãããŠã
ãã ããããªãããäžèšãã€ãã¬ãŒãã¯äžå¿«ãªå¯äœ
çšç¹ã«é çãåŒãèµ·ãããšãç¥ãããŠããããŸ
ããã¢ããã€ãã¬ãŒãã¯äŸãã°ã€ãœãœã«ãããžã
ã€ãã¬ãŒãïŒISDNïŒãããååžåæ§ããããã
ããã«ã€ãœãœã«ãããã€ãœãã³ããããã³ã€ãœã€
ãžãã®ãžãã€ãã¬ãŒãã¯ççºæ§ã§ããã®ã§ãã®è£œ
é ããã³åæ±ãã«ã¯ç¹å¥ã®äºé²æªçœ®ãè¬ããªãã
ã°ãªããªãã ãããã€ãŠã掻æ§ã¹ãã¯ãã«ïŒç¯å²ïŒãåãã§
ã¯ãããäžèšäžå©ç¹ã®ãªãæ°èŠãªè¬å€ããã³ãã®
ãããªè¬å€ã®æå¹æåãšããŠäœ¿çšã§ããæ°èŠãª
ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããããã·ããã¢ãã
ã€ãã¬ãŒãã«å¯ŸããèŠæ±ããªãããŠããã ãã®çºæã¯äžèšèŠæ±ã«çãããã®ã§ãã€ãŠãæ°
èŠãªååç©ãæäŸãããã®ã§ããã ããªãã¡ããã®çºæã¯äžè¬åŒ ã§ç€ºãããïŒâ眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããââã€ãžããâïŒâãã€ãã¬ãŒããäžè¬åŒ ã§ç€ºãããïŒâ眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããââã°ã«ã·ããâïŒâãã€ãã¬ãŒããäžè¬
åŒ ã§ç€ºãããïŒâ眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããââã°ã«ã·ããâïŒâãã€ãã¬ãŒãããã
ã³äžè¬åŒ ã§ç€ºãããïŒâ眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããââãã³ãããâïŒâãã€ãã¬ãŒãïŒäžèš
äžè¬åŒïŒïŒãïŒïŒã«ãããŠãã¯ããã²ã³çœ®
æããšãã«åºãã¡ã¿ã³ã¹ã«ããã«åºãŸãã¯ãã³ã
ãã€ã«åºïŒã䞊ã³ã«ïŒ²ããã³ããã€ã«åºã«ããã
ãã®ççåŠçã«èš±å®¹ã§ããé žä»å å¡©ãæäŸããã
ã®ã§ããã ãã®çºæã®ååç©ã¯å åèæµå¢å€§æ§ãéçæ§ã
è¡å§éäžæ§ãçå€åäœçšé°æ§ããã³å¿ææ°äœäžæ§
çã®å¹æãæã€ããããååç©ã¯å åèçã®åŠ
眮ãçå¿çæ§çºäœã®åŠçœ®ããã³äºé²ãå¿çæ¢å¡ã®
åŸåŠçœ®ã䞊ã³ã«å¿äžå šã®åŠçœ®ã«å¥œé©ã§ããããŸ
ãããã®çºæã®ååç©ã¯æ²»çç¯å²ãè¯å¥œã§ããã
çµå£çåžåãç¹ã«è¯å¥œã§ããããŸãäœçšæéãé·
ããããã«ããããååç©ã¯æ«çšè¡æµããã³è³è¡
æµã®æ¹åãããããã ãã®çºæã®ååç©ã¯ççºæ§ã§ã¯ãªãã®ã§ããã®
補é ããã³åæ±ãã«ãããŠäŸãã°å ¬ç¥ã®ISDNã®
å Žåãããã¯ããã«å±éºæ§ãå°ãªãã ïŒïŒïŒïŒïŒïŒïŒâãžã¢ãœãããããããã®åºæ¬
æ§é ã«ãããŠããã®çºæã®ååç©ã¯ïŒåã®äžæç
çŽ ååãæã¡ãå åŠæŽ»æ§ã®åœ¢æ ã§ååšãããåºçº
ç©è³ªãšããŠã倩ç¶ã«ååšããç³ã¢ã«ã³ãŒã«ãã容
æã«åŸããããšããã®å åŠçã«çŽç²ãªïŒïŒïŒïŒ
ïŒïŒïŒâãžã¢ã³ãããããã·ãããçšããããŠã
ãããã§ããã ãã®çºæã®ååç©ã¯ãšã圢ã®æªçœ®æïŒïŒïŒïŒ
ïŒïŒïŒâãžã¢ã³ãããããã·ãããããããªãã¡
âã€ãœã€ãžããâã€ãœãœã«ããããã³ïŒ€âã€
ãœãã³ããããåºçºããŠä»¥äžã«ç€ºãæ§ã ãªåŸè·¯ã§
補é ã§ããã åèšäžè¬åŒïŒïŒã§ç€ºãããååç©ã§ãã€ãŠïŒ²
ãã¡ã¿ã³ã¹ã«ããã«åºãŸãã¯ãã³ããã€ã«åºã§ã
ããã®ã補é ããããã®ç¬¬ïŒã®æ¹æ³ã¯ããŸãçžå¿
ããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããããã·ããã
ç¡é žãç¡åæ§é žããŸãã¯ç¡é žãšé ¢é žç¡æ°Žç©ïŒé ¢é ž
ãšã®æ··åç©ã§ãå Žåã«å¿ããŠå°¿çŽ ã®ååšäžã«ãšã¹
ãã«åããããšãããªããããã«ãã€ãŠãçžå¿ã
ãã¢ããã€ãã¬ãŒãããã³ãžãã€ãã¬ãŒãã®æ··å
ç©ãåŸãããããžãã€ãã¬ãŒãã®å²åãã§ããã
ãäœãæããããã«ãç¡é žãšã€ãœããã·ããšã®å²
åãåŸè ïŒã¢ã«ã«ã€ãåè ã0.5ãªããïŒã¢ã«ãš
ãªãããã«ããããšã奜ãŸãããåŸãããã¢ãã
ã€ãã¬ãŒããšãžãã€ãã¬ãŒããšã®æ··åç©ããšãŒã
ã«ã§åŠçããæ°Žã§æœåºãããšãã¢ããã€ãã¬ãŒã
ã¯æ°Žçžããåé¢ã§ããäžæ¹äžææã®ãžãã€ãã¬ãŒ
ãã¯ãšãŒãã«çžäžã«å®å šã«æ®ããã€ãœãœã«ããã
ãšã¹ãã«åããå Žåãåå¿çæç©ãã·ãªã«ã²ã«ã
çšããã«ã©ã ã¯ãããã°ã©ãæ³ã«ãã€ãŠåé¢ãã
ããšãæå©ã§ããããã®åé¢æ¹æ³ã«ããã°ããžã
ã€ãã¬ãŒããå®å šã«åé¢ãããã°ããã§ãªããïŒ
çš®é¡ã®ã¢ããã€ãã¬ãŒãããªãã¡ã€ãœãœã«ããïŒ
ïŒãšã³ãïŒâãã€ãã¬ãŒãããã³ã€ãœãœã«ããïŒ
ïŒãšããœïŒãã€ãã¬ãŒããçžäºã«åé¢ãããã ã€ãã§ãçžå¿ããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãã
ãããã·ããã¢ããã€ãã¬ãŒããææã®é žã¯ããª
ãïŒã¡ã¿ã³ã¹ã«ãã³é žã¯ããªããŸãã¯ãã³ãã³é ž
ã¯ããªãïŒãšåå¿ãããŠææã®ååç©ãåŸããã
ã®ç¬¬ïŒã®æ¹æ³ã«ããã°ãäŸãã°ãïŒïŒïŒïŒïŒïŒïŒ
âãžã¢ã³ãããââã€ãžãããç¡é žã§ãšã¹ãã«
åããåŸãããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã€ãžããâïŒâãã€ãã¬ãŒãããã³ãã³é žã¯
ããªããšåå¿ãããããšã«ãã€ãŠïŒïŒïŒïŒïŒïŒïŒ
âãžã¢ã³ãããââã€ãžããâïŒâãã€ãã¬ãŒ
ãâïŒâãã³ãããŒããåŸãããã äžè¬åŒïŒïŒã§ç€ºãããååç©ã§ãã€ãŠïŒ²ãã¡
ã¿ã³ã¹ã«ããã«åºãŸãã¯ãã³ããã€ã«åºã§ããã
ã®ã補é ããããã®ç¬¬ïŒã®æ¹æ³ã¯ããŸããçžå¿ã
ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããããã·ãããæ
æã®é žã¯ããªãïŒã¡ã¿ã³ã¹ã«ãã³é žã¯ããªããŸã
ã¯ãã³ã³é žã¯ããªãïŒãšåå¿ãããããšãããª
ããããã«ãã€ãŠãçžå¿ãããžãšã¹ãã«ããã³ã¢
ããšã¹ãã«ã®æ··åç©ãåŸããããããåå¥çµæ¶ã
åå¥æœåºãããã¯ãã®ä»ã®æ段ã§åé¢ãããã€ã
ã§ãææã®ã¢ããšã¹ãã«ãç¡é žã§ãšã¹ãã«åããŠ
ææã®ååç©ãåŸãã ãã®ç¬¬ïŒã®æ¹æ³ã«åŸã€ãŠãäŸãã°ãïŒïŒïŒïŒ
ïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ããããåºçº
ããŠã¡ã¿ã³ã¹ã«ãã³é žã¯ããªããšåå¿ããããšã
ãŸããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«
ã·ããâïŒâã¡ã¿ã³ã¹ã«ãããŒããçæãããã
ãç¡é žãç¡åæ§é žããŸãã¯ç¡é žãæ°·é ¢é žããã³ç¡
æ°Žé ¢é žã®æ··åç©ãšåå¿ããããšïŒïŒïŒïŒïŒïŒïŒâ
ãžã¢ã³ãããââã°ã«ã·ããâïŒâãã€ãã¬ãŒ
ãâïŒâã¡ã¿ã³ã¹ã«ãããŒããåŸãããã äžè¬åŒïŒïŒã§ç€ºãããååç©ã§ãã€ãŠïŒ²ãã
ãããšãã«åºã§ãããã®ã補é ããããã«ã¯ããŸ
ããåå¿æ§ã€ãœããã·ãã¢ãã¢ã·ã«åç©å¥œãŸãã
ã¯ïŒåèšæ¹æ³ã«æºããŠïŒã€ãœããã·ãã¢ãã¡ã¿ã³
ã¹ã«ãããŒããŸãã¯ã€ãœããã·ãã¢ããã«ãšã³ã¹
ã«ãããŒãã補é ãããããäŸãã°ïœâã¯ããã
ãšããŒã«ãããªãŠã å¡©ã®ãããªææããããšããŒ
ã«ã®é©åœãªå¡©ïŒããã¯çžå¿ããããããšããŒã«ã«
ãããã³å容äœäŸãã°æ°ŽçŽ åãããªãŠã ãæ·»å ã
ãããšã«ãã€ãŠåå¿éçšã®ãã®å Žã§ã補é ã§ã
ãïŒãšåå¿ãããŠææã®ããããšãã«ãšãŒãã«ã
åŸããããããŠåŸãã€ãœããã·ãã®ããããšãã«
ãšãŒãã«ããæ¢è¿°ã®ããã«ãç¡é žã§ãšã¹ãã«åã
ãŠã¢ããã€ãã¬ãŒããåŸããããããšãã«åºã®ç¡
åãé¿ããããã«ããã®ãšã¹ãã«åã¯å¥œãŸããã¯
ïŒâ以äžã§ãããªãã äžèšãšãŒãã«åã¯ææž©äžã«äºæ¥µæ§éãããã³æº¶
åªäŸãã°ãžã¡ãã«ã¹ã«ããã·ããŸãã¯ã°ãªã³ãŒã«
ãžãšãŒãã«äžã§ãããªãã®ã奜ãŸãããå žåçãª
äºååçæ±æ žçœ®æåå¿ïŒSNïŒåå¿ïŒã«åŸã€ãŠç
ããããã®ã¿ã€ãã®åå¿ã¯äžå¿ççŽ ååäžã«ãã
ãç«äœé 眮ã®é転ãåžžã«äŒŽãªãããã®ç«äœé 眮ã
é転ïŒããã¯ãå転ããŸãã¯ãã¯ã«ãã³å転ããš
ãåŒã°ããŠããïŒããããšããã¢ã·ã«åºãïŒäœã§
ãšã³ãæ¹åã«ç«ã¡äžãã€ãŠããïŒïŒïŒïŒïŒïŒïŒâ
ãžã¢ã³ãããââã°ã«ãžããâïŒâã¢ã·ã«èªå°
äœãããæ°ãã«å°å ¥ãããããããšãã«ãšãŒãã«
åºããšã³ãäœã§ã¯ãªããšããœäœã«ç«ã¡äžãã€ããš
ãŒãã«åïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€
ãžããèªå°äœãåžžã«åŸãããçç±ã§ãããSNïŒ
åå¿ã«ãããŠã¯ãã®ããã«ã¯ã«ãã³å転ãçãã
ã®ã§ãçžå¿ããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã€ãžããã¢ã·ã«åç©ããïŒäœã«ãšã³ã眮æã
ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ã
ããšãŒãã«ãåŸãããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããââãã³ãããã¢ã·ã«åç©ããïŒäœã«ãšã
ãœçœ®æããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââ
ã°ã«ã·ãããšãŒãã«ãåŸãããïŒïŒïŒïŒïŒïŒïŒâ
ãžã¢ã³ãããââã°ã«ã·ããâïŒâãšããœâã¢
ã·ã¬ãŒãããïŒäœã«ãšã³ã眮æããïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããââãã³ããããšãŒãã«ãåŸ
ãããã®ã§ããã ãã®ç¬¬ïŒã®æ¹æ³ã«åŸããšãäžè¬åŒïŒïŒããã³
ïŒïŒã§ç€ºãããååç©ã§ãã€ãŠïŒ²ããã³ããã€
ã«åºã§ãããã®ã補é ã§ãããã®å Žåãã³ãã³é ž
æ®åºã¯çžå¿ããã€ãœãœã«ãããããã¯ã€ãœã€ãžã
ãã€ãã¬ãŒãã®ïŒïŒãšããœïŒäœãããã¯ïŒïŒãšã
ãœïŒäœãå ããããããååç©ã補é ããã«ã¯ã
ãšã³ãæ¹åã«ç«ã¡äžãã€ãã¡ã¿ã³ã¹ã«ããã«åºã
æããã€ãœããã·ãã¡ã¿ã³ã¹ã«ãããŒããææž©äž
ã«äºæ¥µæ§éãããã³æº¶åªäŸãã°ãžã¡ãã«ãã«ã ã¢
ããäžã§ãã³ãã³é žã®é©åœãªå¡©äŸãã°ãã³ãã³é ž
ãããªãŠã ã«ãã€ãŠSNïŒåå¿ã«äŸããããã®å Ž
åãã眮æäœã§ç«äœé 眮ã®é転ãçãããããã³
ãã³é žå¡©ã®æ±æ žåã¯ç«äœçã«ãã匷åºã«é害ãã
ãŠããã€ãœããã·ããšããœâã¡ã¿ã³ã¹ã«ãããŒã
ãã眮æããã«ã¯äžå åã§ããã ããããŠåŸãããã€ãœããã·ããã³ãããŒãã
æ¢è¿°ã®ããã«ç¡é žã§ãšã¹ãã«åããŠã€ãœããã·ã
ãã³ãããŒããã€ãã¬ãŒããåŸãããã®ããã«ã
ãŠãäŸãã°ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã°ã«ã·ããâïŒâã¡ã¿ã³ã¹ã«ãããŒãããžã¡ã
ã«ãã«ã ã¢ããäž150âã§ãã³ãã³é žãããªãŠã
ãšåå¿ãããŠïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã€ãžããâïŒâãã³ãããŒããåŸãããã€ãã§
ãããç¡é žã§ãšã¹ãã«åããŠææã®ïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããââã€ãžããâïŒâãã³ãã
ãŒãâïŒâãã€ãã¬ãŒããåŸãããã äžè¬åŒïŒïŒã§ç€ºãããååç©ã§ãã€ãŠïŒ²ãã
ã³ããã€ã«åºã§ãããã®ããã®ççåŠçã«èš±å®¹ã§
ããå¡©ã«è»¢åããããã«ã¯ãç¡æ©é žããã³é±é žäŸ
ãã°ããã²ã³åæ°ŽçŽ é žããã³ãªã³é žäžŠã³ã«ã«ã«ã
ã³é žãã¹ã«ãã³é žã®ãããªææ©é žäŸãã°ããã³
é žãã³ãã¯é žãä¹³é žãé ç³é žããªã³ãŽé žãå®æ¯éŠ
é žãã¯ãšã³é žãã¢ã¹ã³ã«ãã³é žãŸãã¯ïœâãã«ãš
ã³ã¹ã«ãã³é žãçšããããšãã§ããããã®é žä»å
å¡©ãå¡©åºäŸãã°çé žæ°ŽçŽ ãããªãŠã ãããã¯ã«ãª
ãŠã ã§æ³šææ·±ãåŠçãããšéé¢ã®å¡©åºãåã³åé¢
ãããã ãã®çºæã¯è¬å€çµæç©ã«ãä¿ããããã¯éåžžã®
æ äœããã³æ·»å å€ã«å ããŠãã®çºæã®ååç©ãŸã
ã¯ãã®ççåŠçã«èš±å®¹ã§ããå¡©ã®ãã¡ã®å°ãªããš
ãïŒçš®ãå«ãã§ããããã®çµæç©ã¯äººäœã«å¯Ÿãå»
è¬ãšããŠããã³ç£å»è¬ãšããŠçšããããšãã§ã
ããéåžžã®æ äœãšããŠã¯ãäŸãã°ãæ°Žãæ€ç©æ²¹ã
ããªãšãã¬ã³ã°ãªã³ãŒã«ãã°ãªã»ãªã³ãšã¹ãã«ã
ãŒã©ãã³ãçåæ°ŽçŽ äŸãã°ã©ã¯ããŒã¹ãŸãã¯ã¹ã¿
ãŒããã¹ãã¢ãªã³é žãã°ãã·ãŠã ãã¿ã«ã¯ãã¯ã»
ãªã³ããããéåžžã®æ·»å å€ãšããŠã¯ãäŸãã°ãé²
è å€ãå®å®å€ã最æ»å€ã湿最å€ãä¹³åå€ãççåŠ
çã«èš±å®¹ã§ããå¡©ãç·©è¡å€ãçè²å€ã颚å³å€ãéŠ
æããããæ äœããã³æ·»å å€ã¯ãã®çºæã®ååç©
ãçµè žãéçµå£ãå±æã®ãããã«ãã€ãŠæäžãã
ããã«ãã€ãŠéžæããã ãã®çºæã®ååç©ã¯ä»ã®æŽ»æ§ç©è³ªäŸãã°ãã¿ã
ã³é¡ãŸãã¯åžè²©ã®å¿åŸªç°å€ãšãšãã«ãããã«ç¹ã«
βâå容äœé»æ¢ç©ãšãšãã«æäžããããšãã§ã
ãã è¬å€çµæç©ã®äŸ åïŒmgã®æŽ»æ§ç©è³ªãå«æããå100mgã®é å€ã
補é ããããã«ã以äžã®ç©è³ªãå¿ èŠãšãããã ïŒïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°
ã«ã·ããâïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒ
ãïŒïŒïœïŒ ïŒïŒ 埮çµæ¶ã»ã«ããŒã¹ïŒ54ïœïŒ ïŒïŒ ã©ã¯ããŒã¹ïŒ20ïœïŒ ïŒïŒ ãšãããããã¹ã¿ãŒãïŒ20ïœïŒ ïŒïŒ ã³ãã€ãç¶ã±ã€é žïŒ0.5ïœïŒ ïŒïŒ ã¹ãã¢ãªã³é žãã°ãã·ãŠã ïŒ0.5ïœïŒ ïŒïŒãïŒïŒã®ç©è³ªã10åé也ç¥æ··åããã€
ãã§ãã®æ··åç©ãç©è³ªïŒïŒããã³ïŒïŒã«å
ããããã«10åéæ··åããåŸãããç²æ«ãé å€æ©
ã§ãã¬ã¹ããŠåã 100mgã®é å€ãåŸãã 以äžãå®æœäŸãèšããåå®æœäŸã§åŸãååç©ã
ãã³äžéäœã¯è¬å€çµæç©çšã«ç¹ã«å¥œé©ãªãã®ã§ã
ãã å®æœäŸäžã®åç¥å·ã¯æ¬¡ã®æå³ãè¡šããã m.p.âŠâŠèç¹ïŒéä¿®æ£ïŒ ïœâŠâŠå¯åºŠ ãαã25 DâŠâŠ25âã§ã®å åŠå転ããããªãŠã 
ç·å åŠå転å€ã®æ¬¡ã«ã枬å®ãã溶液ã®æ¿åºŠã瀺ã
ããŠãããäŸãã°ãc2ã¯æ¿åºŠïŒïœïŒ100ml溶液ã
æå³ãããããããã®æº¶åªã¯å¥ã ã«ç€ºããŠããã å®æœäŸ ïŒ ïŒââïŒïŒâã¯ããããšãã«ïŒâïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããââã€ãžããâïŒâãã€ã
ã¬ãŒãïŒ ïœ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ãããïŒâã¡ã¿ã³ã¹ã«ãããŒããïŒâã¡ã¿ã³ã¹
ã«ãããŒãããã³ïŒïŒïŒâãžã¡ã¿ã³ã¹ã«ãããŒ
ãïŒ ããªãžã³24äžã®ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããââã°ã«ã·ãã4.82KgïŒ33ã¢ã«ïŒæº¶æ¶²ã«
æ°Žåãæé€ããæ¹æããªããâ15âãâ20âã«
å·åŽãã€ã€æ°æéãããŠã¡ã¿ã³ã¹ã«ãã³é žã¯ã
ãªã3.1ïŒ40ã¢ã«ïŒã滎äžããããã®åŸå·åŽ
ããããšãªãããã«15æéæ¹æãããç空äžã§
ããªãžã³ãçå»ããæ²¹ç¶æ®æž£ãæ°Ž15ã«å ãã
沞隰ãããå·åŽãããåžåŒãéããæ°ŽïŒã§æŽ
æµããçµæ¶æ²ã§ãã也ç¥ããŠïŒïŒïŒïŒïŒïŒïŒâ
ãžã¢ã³ãããââã°ã«ã·ããâïŒïŒïŒâãžã¡
ã¿ã³ã¹ã«ãããŒã2.22KgïŒ7.34ã¢ã«ïŒãåŸãã
ã液ããæ¹æãæ°Žå·ããªããæ°Žé žåãããªãŠã
çŽ1.5Kgã§äžåããç空äžçŽ70âã§èžçºä¹Ÿåºã
ãã也ç¥æ®æž£ãå šéšã§30ã®ã¯ãããã«ã ã§é£
ç¶çã«ç±æœåºããæœåºç©ãç±éãéããããã®
æœåºç©ã20âã§15æéæŸçœ®ããçµæ¶æ²ã§ããåž
åŒãéããïŒã®ã¯ãããã«ã ã§ïŒåæŽæµãã
也ç¥ããŠïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââ
ã°ã«ã·ããâïŒâã¡ã¿ã³ã¹ã«ãããŒã2.3Kg
ïŒ10.26ã¢ã«ïŒãåŸããã液ãåãããŠç空äžã§
èžçºãããæ®æž£ããšã¿ããŒã«22ã«ç±é溶解ã
ããããã20âã§15æéæŸçœ®ããçµæ¶æ²ã¹ãã
åžåŒãéããïŒã®ãšã¿ããŒã«ã§ïŒåæŽæµãã
也ç¥ããŠïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââ
ã°ã«ã·ããâïŒâã¡ã¿ã³ã¹ã«ãããŒã0.65Kg
ïŒ2.90ã¢ã«ïŒãåŸããã液ãèžçºãããŠåŸïŒè
ã®ç°æ§äœã¢ãã¡ã¿ã³ã¹ã«ãããŒãæ··åç©2.21Kg
ïŒ9.85ã¢ã«ïŒãåŸããããã¯ã¯ãããã«ã ãã
ã®åçµããã³ãšã¿ããŒã«ããã®åçµã亀äºã«ã
ãããããããªãããšã«ãã€ãŠããã«åé¢ã§
ãããããã¯ããªãžã³äžã§ã¡ã¿ã³ã¹ã«ãã³é žã¯
ããªãã§ãšã¹ãã«åããããšã«ãã€ãŠïŒïŒïŒïŒ
ïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ããâïŒïŒ
ïŒâãžã¡ã¿ã³ã¹ã«ãããŒãã«å®å šã«è»¢åããã åçµæ¶åŸã®ã¡ã¿ã³ã¹ã«ãããŒãã®ç©æ§ã次衚
ã«ãŸãšããã ãè¡šã ãè¡šã ïœ ïŒâïŒïŒâã¯ããããšãã«ïŒâïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããââã€ãžããïŒ ç¡æ°Žãžã¡ãã«ã¹ã«ããã·ãïŒDMSOïŒ70ml
äžïŒâã¯ããããšããŒã«13.0ïœïŒ0.1ã¢ã«ïŒæº¶
液ã«æ°ŽçŽ åãããªãŠã 2.4ïœïŒ0.1ã¢ã«ïŒãåŸã
ã«å ãããæ¹æããæ°Žåãæé€ããŠ80âã«ç±
ããç¡æ°ŽDMSO30mläžïŒïŒïŒïŒïŒïŒïŒâãžã¢
ã³ãããââã°ã«ã·ããâïŒâã¡ã¿ã³ã¹ã«ã
ããŒã11.2ïœïŒ0.05ã¢ã«ïŒæº¶æ¶²ã滎äžããã80
âã§24æéæ¹æããåŸå·åŽããæªåå¿æ°ŽçŽ åã
ããªãŠã ãå æ°Žå解ããããã«æ°Žã滎äžããã€
ãã§æ°Ž100mlããã³ã¯ãããã«ã 200mlãå ã
ããå åã«æ¹æããã¯ãããã«ã çžãåé¢ãã
ãããæ°Ž200mlã1Mæ°Žé žåãããªãŠã 氎溶液
100mlããã³æ°Ž100mlã§é 次æ¯çªããç¡æ°Žç¡«é žã
ããªãŠã äžã§ä¹Ÿç¥ããç空äžã§èžçºããããªã€
ããæ®æž£ãã¯ãããã«ã ïŒãšã¿ããŒã«ããåçµ
æ¶ãããŠïŒâïŒïŒâã¯ããããšãã«ïŒâïŒïŒ
ïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžãã11.5
ïœïŒ45ããªã¢ã«ïŒãåŸããåæå€ã¯ä»¥äžã®ãšã
ãã§ãã€ãã m.p.107ã110âïŒãαã25 D17.0ïŒc2ïŒã¯ãããã«
ã ïŒ å çŽ åæ ïŒC12H13ClO4ïŒïŒ256.68ïŒïŒ ãè¡šã ïœ ïŒâïŒïŒâã¯ããããšãã«ïŒâïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããââã€ãžããâïŒâãã€ã
ã¬ãŒãïŒ é ¢é ž150mlããã³ç¡æ°Žé ¢é ž35mläžïŒââïŒïŒ
âã¯ããããšãã«ïŒâïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³
ãããââã€ãžãã13ïœïŒ50ããªã¢ã«ïŒæº¶æ¶²
ã«ãæ¹æã10âã«å·åŽããªããæ°·é ¢é ž50mlãã
ã³ç¡æ°Žé ¢é ž12.5mläž65ïŒ ç¡é ž3.5ml溶液ãïŒæ
éã§æ»ŽäžããåŸã ã«å®€æž©ãŸã§å æž©ããªããäžæ©
æ¹æãããã¯ãããã«ã ããã³æ°Žããããã
250mlãã€å ããæ¹æããã¯ãããã«ã çžãå
é¢ãããããæ°Ž250mlã§æŽæµãããç¡æ°Žç¡«é žã
ããªãŠã äžã§ä¹Ÿç¥ããåŸãæžå§äžã§èžçºãã
ããæ²¹ç¶æ®æž£ããšã¿ããŒã«ããåçµæ¶ãããŠïŒ
âïŒïŒâã¯ããããšãã«ïŒâïŒïŒïŒïŒïŒïŒïŒâ
ãžã¢ã³ãããââã€ãžããâïŒâãã€ãã¬ãŒ
ã13.3ïœïŒ44ããªã¢ã«ïŒãåŸããåæçµæã¯æ¬¡
ã®ãšããã§ãã€ãã m.p.76ã77âïŒãαã25 D41.4ïŒc2ïŒã¯ãããã«
ã ïŒ å çŽ åæ ïŒC12H12ClNO6ïŒïŒ301.63ïŒïŒ ãè¡šã å®æœäŸ ïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžãã
âïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒãïŒ ïœ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžã
ãâïŒâãã€ãã¬ãŒãïŒ é ¢é ž800mlããã³ç¡æ°Žé ¢é ž280mläžïŒïŒïŒïŒ
ïŒïŒïŒâãžã¢ã³ãããââã€ãžãã62ïœ
ïŒ0.42ã¢ã«ïŒæº¶æ¶²ã«ãæ¹æããïŒã10âã«å·åŽ
ããªããã95ïŒ ç¡é žïŒå¯åºŠ1.5ïŒ18.5ïœïŒ0.42ã¢
ã«ïŒãé ¢é ž400mlããã³ç¡æ°Žé ¢é ž100mlãããªã
æ··åç©ã滎äžãã12æéæ¹æããããããæ°Ž
3.5ã§åžéããçé žæ°ŽçŽ ãããªãŠã ãåŸã ã«
å ããŠäžåããã¯ãããã«ã 1000mlã§ïŒåæœåº
ããã¯ãããã«ã æœåºæ¶²ãèžçºãããç¡æ°Žç¡«é ž
ãããªãŠã äžã§ä¹Ÿç¥ããæžå§äžã§ã»ãŒä¹Ÿåºãã
ããããããŠåŸãã¢ããã€ãã¬ãŒããšãžãã€ã
ã¬ãŒãã®æ··åç©ããšãŒãã«250mlã«æº¶è§£ããæ°Ž
100mlã§10åæœåºãããæ°Žçžã¯ã¢ããã€ãã¬ãŒ
ãïŒRfïŒ0.47ïŒã·ãªã«ã²ã«ä»äžããã¬ãŒããã¯
ãããã«ã ïŒã¡ã¿ããŒã«ïŒïŒïŒïŒïŒãå«æããŠ
ããããžãã€ãã¬ãŒãïŒRfïŒ0.75ïŒã¯ãšãŒãã«
çžäžã«æ®ã€ããæ°Žçžãå¡©åãããªãŠã ã§é£œå
ããã¯ãããã«ã 200mlã§ïŒåæœåºããæžå§äž
ã§ã¯ãããã«ã æœåºæ¶²ãèžçºãããŠç¡è²æ²¹ã®åœ¢
æ ã«ããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââ
ã€ãžããâïŒâãã€ãã¬ãŒã32.1ïœïŒ0.17ã¢
ã«ïŒãåŸããããã¯ããã«ç²Ÿè£œããããšãªã以
åŸã®ãšã¹ãã«åã«çšããã ïœ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžã
ãâïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒãïŒ ç¡æ°Žããªãžã³150mlãïŒïŒïŒïŒïŒïŒïŒâãžã¢
ã³ãããââã€ãžããâïŒâãã€ãã¬ãŒã
9.5ïœïŒ50ããªã¢ã«ïŒããã³ãã³ãã³é žã¯ããª
ã7.7ïœïŒ55ããªã¢ã«ïŒãããªãæ··åç©ãæ°Žå
ãæé€ããŠ20â24æéæ¹æãããæžå§ïŒ10ããª
ããŒã«ïŒäžã§ããªãžã³ãèžçºãããæ®æž£ãçé ž
æ°ŽçŽ ãããªãŠã 氎溶液ã§äžåããæžå§äžã§åã³
èžçºãããæ®æž£ã沞隰ã¯ãããã«ã ã§æœåºã
ããã¯ãããã«ã æœåºæ¶²ãèžçºããç¡æ°Žç¡«é žã
ããªãŠã äžã§ä¹Ÿç¥ããã¡ã¿ããŒã«ããåçµæ¶ã
ããŠïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãž
ããâïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒã
11.8ïœïŒ40ããªã¢ã«ïŒãåŸããåæçµæã¯æ¬¡ã®
ãšããã§ãã€ãã m.p.81ã83âïŒãαã25 D111ïŒc2ïŒã¯ãããã«
ã ïŒ å çŽ åæ ïŒC12H12N2O7ïŒïŒ296.24ïŒïŒ ãè¡šã å®æœäŸ ïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžãã
âïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒãïŒ ïœ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžã
ãâïŒâãã³ãããŒãïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâã¡ã¿ã³ã¹ã«ãããŒãïŒå®æœäŸ1aïŒ
ã«åŸã€ãŠè£œé ïŒ45ïœïŒ0.2ã¢ã«ïŒããã³ãã³é žã
ããªãŠã 32ïœïŒ0.22ã¢ã«ïŒããã³ç¡æ°Žãžã¡ãã«
ãã«ãã¢ãã500mlãããªãæ··åç©ã150âã§15
æéæ¹æããã溶åªãçå»ããæ®æž£ãæ°Ž200ml
ã«æº¶è§£ãã掻æ§çïŒïœãå ãããéãããã液
ãåžæ°Žé žåãããªãŠã 氎溶液ã§PHïŒãïŒã«èª¿ç¯
ããã¯ãããã«ã 200mlã§ïŒåæœåºãããã¯ã
ããã«ã æœåºæ¶²ãåããã0.25Må¡©é ž200mlã§
ïŒåæœåºããå¡©é žæœåºæ¶²ãåãããã¯ãããã«
ã 200mlã§æŽæµããæžå§äžã§èžçºãããšã¿ããŒ
ã«ïŒã¯ãããã«ã ã§å ±æ²žä¹Ÿç¥ãããæ®æž£ããšã¿
ããŒã«ïŒã€ãœãããããŒã«ããåçµæ¶ãããŠ
ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžãã
âïŒâãã€ãã¬ãŒããããã¯ããªãçµæ¶17.4ïœ
ïŒ60.6ããªã¢ã«ïŒãåŸããåæçµæã¯æ¬¡ã®ãšã
ãã§ãã€ãã m.p.148ã150âïŒãαã25 D52.6ïŒc10ïŒæ°ŽïŒïŒ å çŽ åæ ïŒC12H13NO5ã»xHClïŒïŒ287.70ïŒ ãè¡šã ïœ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžã
ãâïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒãïŒ 95ïŒ ç¡é ž50mläžå°¿çŽ 3.5ïœïŒ58ããªã¢ã«ïŒæº¶
液ã«ãæ¹æããâ20âã«å·åŽãã€ã€ãã¡ã¿ã³ã¹
ã«ãã³é ž30mläžïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ããã
ââã€ãžããâïŒâãã³ãããŒãïŒäžèšïœïŒ
ã§åŸãããã¯ããªãã®éé¢å¡©åºïŒ14ïœïŒ56ããª
ã¢ã«ïŒã滎äžããâ20âã§ïŒæéæ¹æããæ°·æ°Ž
200mlã«æ³šäžããå·åŽãã€ã€ãæ°Ž200mlã«æº¶è§£ã
ãæ°Žé žåãããªãŠã 65ïœã滎äžãããçé žæ°ŽçŽ
ãããªãŠã ãå ããŠäžåãå®çµãããã¯ããã
ã«ã 100mlã§ïŒåæœåºãããæœåºæ¶²ãåããã
æ°Ž100mlã§æŽæµããç¡æ°Žç¡«é žãããªãŠã äžã§ä¹Ÿ
ç¥ããæžå§äžã§èžçºããŠç¡è²ã§ãã€ãããšåºå
ããæ²¹ã®åœ¢æ ã«ããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããââã€ãžããâïŒâãã€ãã¬ãŒãâïŒâ
ãã³ãããŒã10.8ïœïŒ36.5ããªã¢ã«ïŒãåŸãã
ãããã¯ãããã«ã ã«æº¶è§£ããå¡©é žäžã«éããŠ
ãšãŒãã«ã§ãããã¯ããªããæåºãããã€ãœã
ããããŒã«ïŒãšãŒãã«ããåçµæ¶ãããã m.p.151ã152âïŒå解ïŒïŒãαã25 D77.2ïŒc0.5ïŒ
ãšã¿ããŒã«ïŒ å çŽ åæ ïŒC12H12N2O7ã»xHClïŒ
ïŒ332.69ïŒïŒ ãè¡šã å®æœäŸ ïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ã
ãâïŒâãã€ãã¬ãŒãâïŒâã¡ã¿ã³ã¹ã«ãããŒ
ãïŒ é ¢é ž200mlããã³ç¡æ°Žé ¢é ž75mläžïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããââã°ã«ã·ããâïŒâã¡ã¿ã³
ã¹ã«ãããŒãïŒå®æœäŸ1aïŒã«åŸã€ãŠè£œé ïŒ22.4ïœ
ïŒ100ããªã¢ã«ïŒæº¶æ¶²ã«ãæ¹æã10âã«å·åŽãã€
ã€ãé ¢é ž100mlããã³ç¡æ°Žé ¢é ž25mläž95ïŒ ç¡é ž4.5
mlïŒ100ããªã¢ã«ïŒæº¶æ¶²ã滎äžããåŸã ã«å®€æž©ã«
å æž©ããªããïŒæéæ¹æããæ°Ž1200mlãå ããç
é žæ°ŽçŽ ãããªãŠã ã§å°ãã¥ã€äžåããã¯ãããã«
ã 300mlã§ïŒåæœåºãããã¯ãããã«ã æœåºæ¶²ã
ç¡æ°Žç¡«é žãããªãŠã äžã§ä¹Ÿç¥ããæžå§äžã§èžçºã
ããã¯ãããã«ã ïŒãšãŒãã«ããåçµæ¶ãããŠ
ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ãã
âïŒâãã€ãã¬ãŒãâïŒâã¡ã¿ã³ã¹ã«ãããŒã
22.6ïœïŒ84ããªã¢ã«ïŒãåŸãã m.p.105ã106âïŒãαã25 D91ïŒc2.0ïŒã¯ãããã«
ã ïŒ å çŽ åæ ïŒC7H11NO8SïŒïŒ269.24ïŒïŒ ãè¡šã å®æœäŸ ïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ã
ãâïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒãïŒ ïœ ç¡é žã«ããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã°ã«ã·ããã®ãšã¹ãã«åïŒ ç¡æ°Žããªãžã³1500mläžïŒïŒïŒïŒïŒïŒïŒâãžã¢
ã³ãããââã°ã«ã·ãã73ïœïŒ500ããªã¢ã«ïŒ
溶液ããæ¹æãæ°Žåãæé€ãã10âã«å·åŽãã€
ã€ãå šéšã§72ïœïŒ500ããªã¢ã«ïŒã®ãã³ãã³é ž
ã¯ããªããšåŸã ã«æ··åããè©²é žã¯ããªãã®åå¿
ãå®çµãããŸã§ïŒçŽïŒæéïŒ50ã60âã§æ¹æã
ããæžå§äžã§ããªãžã³ãçå»ããæ®æž£ãçé žæ°Ž
çŽ ãããªãŠã 氎溶液ã§PHïŒã«èª¿ç¯ããæžå§äžã§
åã³èžçºãããæ®æž£ã沞隰ã¯ãããã«ã 400ml
ã§ïŒåæœåºãããã¯ãããã«ã æœåºæ¶²ãåãã
500mlã«æ¿çž®ããæ°ŽïŒïŒïŒïŒ ãšã¿ããŒã«ïŒã移
åäžå±€ãšããŠçšãã40段ã®ã¯ã¬ã€ã°åæµåé æ³
ã«äŸãããåãã©ã¯ã·ãšã³ãèå±€ã¯ãããã°ã©
ãæ³ïŒã·ãªã«ã²ã«F254ä»äžããã¬ãŒããã¯ã
ããã«ã ïŒã¡ã¿ããŒã«ïŒ9/1ïŒã§åé¢ãããã®
åæåã«åŸã€ãŠäžç·ã«ããèžçºãããã以äžã«
瀺ãåãã©ã¯ã·ãšã³ããããããã®ååç©ãåŸ
ãã ãã©ã¯ã·ãšã³ïŒãïŒããïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒïŒïŒâãžãã³ãããŒãïŒRfïŒ0.49ïŒ
48.5ïœïŒ136ããªã¢ã«ïŒãã¯ãããã«ã ïŒãšãŒã
ã«ããã®åçµæ¶åŸã®m.pïŒ142ã144âïŒæç®å€
ïŒè±åœç¹èš±ç¬¬1027891å·ïŒ143.5ã144âïŒããαã
25 D30.0ïŒc2.0ãã¯ãããã«ã ïŒïŒæç®å€ïŒ28.8ïŒ
ã¯ãããã«ã ïŒãå çŽ åæïŒC18H16N2O6ïŒ
ïŒ356.34ïŒïŒ ãè¡šã ãã©ã¯ã·ãšã³ïŒã14ããïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâãã³ãããŒãïŒRfïŒ0.32ïŒ18.6ïœ
ïŒ74ããªã¢ã«ïŒãã¯ãããã«ã ïŒç³æ²¹ãšãŒãã«ã
ãåçµæ¶åŸã®m.pïŒ112ã113.5âããαã25 D69.8
ïŒc2.0ïŒã¯ãããã«ã ïŒãå çŽ åæ
ïŒC12H13NO5ïŒïŒ251.24ïŒïŒ ãè¡šã ãã©ã¯ã·ãšã³15ã19ããïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâããã³ïŒâãã³ãããŒãæ··åç©4.5
ïœïŒ18ããªã¢ã«ïŒã ãã©ã¯ã·ãšã³20ã36ããïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâãã³ãããŒãïŒRfïŒ0.25ïŒ30.6ïœ
ïŒ122ããªã¢ã«ïŒãã¯ãããã«ã ïŒãšãŒãã«ãã
åçµæ¶åŸã®m.p.ïŒ84ã85.5âããαã25 D55.4
ïŒc2.0ïŒã¯ãããã«ã ïŒãå çŽ åæ
ïŒC12H13NO5ïŒïŒ251.24ïŒïŒ ãè¡šã ãªãããã©ã¯ã·ãšã³37ã40ã¯æªåå¿ã®ïŒïŒ
ïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ããã
å«ãã§ããã ïœ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒãïŒ é ¢é ž300mlããã³ç¡æ°Žé ¢é ž70mläžïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããââã°ã«ã·ããâïŒâãã³
ãããŒã25ïœïŒ100ããªã¢ã«ïŒæº¶æ¶²ã«ãæ¹æã
10âã«å·åŽãã€ã€ãé ¢é ž100mläž95ïŒ ç¡é ž6.6ml
ïŒ150ããªã¢ã«ïŒæº¶æ¶²ãåŸåŸã«æ»Žäžããããã«å
枩床ã§ïŒæéæ¹æããããããæ°Ž1500mlã§åžé
ããçé žæ°ŽçŽ ãããªãŠã ãå°ãã¥ã€å ããŠäžå
ããé ¢é žãšãã«500mlã§ïŒåæœåºãããæœåºæ¶²
ãåããçé žæ°ŽçŽ ãããªãŠã 氎溶液ã§æŽæµãã
ç¡æ°Žç¡«é žãããªãŠã äžã§ä¹Ÿç¥ããæžå§äžã§èžçº
ãããã¡ã¿ããŒã«ïŒæ°Žããåçµæ¶ãããŠïŒïŒ
ïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ããâ
ïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒã23.7ïœ
ïŒ80ããªã¢ã«ïŒãåŸãã m.pïŒ107ã108.5âïŒãαã25 D58.0ïŒc2.0ïŒã¯ã
ããã«ã ïŒ å çŽ åæ ïŒC12H12N2O7ïŒïŒ296.24ïŒ ãè¡šã å®æœäŸ ïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ã
ãâïŒâãã³ãããŒãâïŒâãã€ãã¬ãŒãïŒ å®æœäŸ5aïŒã§åŸãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ã
ããââã°ã«ã·ããâïŒâãã³ãããŒã12.5ïœ
ïŒ50ããªã¢ã«ïŒãç¡é žïŒç¡æ°Žé ¢é žïŒé ¢é žãšåå¿ã
ããã¯ãããã«ã ïŒãšãŒãã«ããåçµæ¶ãããŠ
ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ãã
âïŒâãã³ãããŒãâïŒâãã€ãã¬ãŒã10.7ïœ
ïŒ36ããªã¢ã«ïŒãåŸãã m.p.ïŒ54ã57âïŒãαã25 D117.2ïŒc2.0ïŒã¯ããã
ã«ã ïŒ å çŽ åæ ïŒC12H12N2O7ïŒïŒ296.24ïŒïŒ ãè¡šã å®æœäŸ ïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ã
ãâïŒâãã³ãããŒãâïŒâãã€ãã¬ãŒãïŒ ïœ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâããã³ïŒâãã€ãã¬ãŒãïŒ é ¢é ž300mlããã³ïŒç¡æ°Žé ¢é ž70mläžïŒïŒïŒïŒ
ïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ãã30ïœ
ïŒ200ããªã¢ã«ïŒæº¶æ¶²ã«ãæ¹æããïŒâã«å·åŽã
ã€ã€ãé ¢é ž50mläž65ïŒ ç¡é žïŒmlïŒ100ããªã¢ã«ïŒ
溶液ã滎äžããïŒæéæ¹æããããããæ°Ž1000
mlã§åžéããé ¢é žãšãã«500ã§ïŒåæœåºããã
æœåºæ¶²ãåãããæ¹æããªããçé žæ°ŽçŽ ãããª
ãŠã 氎溶液ãå°ãã¥ã€å ããŠäžåãããé ¢é žãš
ãã«çžãåé¢ããç¡æ°Žç¡«é žãããªãŠã äžã§ä¹Ÿç¥
ããæžå§äžã§çŽ50mlãŸã§æ¿çž®ããããã®æ¿çž®ç©
ããæµåºæ¶²ãšããŠãã«ãšã³ïŒé ¢é žãšãã«ïŒ1/1ïŒ
ãçšãã·ãªã«ã²ã«ïŒKgã§ã«ã©ã ã¯ãããã°ã©ã
æ³ã«ããåé¢ããã RfïŒ0.26ïŒã·ãªã«ã²ã«F254ä»äžããã¬ãŒãã
ãã«ãšã³ïŒé ¢é žãšãã«ïŒ1/1ïŒã®ãã©ã¯ã·ãšã³
ãæžå§äžã§èžçºããããšãŒãã«ããåçµæ¶ãã
ãŠïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâãã€ãã¬ãŒã2.6ïœïŒ13.6ããªã¢ã«ïŒ
ãåŸãã m.p.ïŒ53ã55.5âïŒæç®ïŒL.D.ãã€ã¯ãŒãä»
Can.J.Chem.ïŒ45ïŒ2191ãïŒïŒ1967ïŒå€52ã
53âïŒãαã25 D76.4ïŒc2.0ïŒã¯ãããã«ã ïŒãå
çŽ åæïŒC6H9NO6ïŒïŒ191.15ïŒïŒ ãè¡šã RfïŒ0.20ã®ãã©ã¯ã·ãšã³ãæžå§äžã§èžçºã
ããé ¢é žãšãã«ïŒç³æ²¹ãšãŒãã«ããåçµæ¶ãã
ãŠïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâãã€ãã¬ãŒã8.8ïœïŒ46ããªã¢ã«ïŒ
ãåŸãã m.p.86ã88âïŒæç®å€89.5ã91âïŒïŒãαã25 D
163.4ïŒc2.0ïŒã¯ãããã«ã ïŒ å çŽ åæ ïŒC6H9NO6ïŒïŒ191.15ïŒ ãè¡šã ïœ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâãã³ãããŒãâïŒâãã€ãã¬ãŒãïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâãã€ãã¬ãŒããå®æœäŸ2bïŒãšåæ§
ã®ææ³ã§ããªãžã³äžã§ãã³ãã³é žã¯ããªããšå
å¿ãããã¯ãããã«ã ïŒãšãŒãã«ããåçµæ¶ã
ããŠïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«
ã·ããâïŒâãã³ãããŒãâïŒâãã€ãã¬ãŒã
9.0ïœïŒ30.4ããªã¢ã«ïŒãåŸãã m.p.ïŒ55ã57â ãαã25 D117ïŒc2ïŒã¯ãããã«ã ïŒ å®æœäŸ ïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââãã³ãã
ãâïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒãïŒ é ¢é ž100mläžïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âãã³ãããâïŒâãã³ãããŒã10.3ïœïŒ41ã
ãªã¢ã«ïŒæº¶æ¶²ã«ç¡æ°Žé ¢é ž20mlããã³å°¿çŽ 0.6ïœã
å ããæ¹æã10âã«å·åŽãã€ã€ãé ¢é ž20mläž96ïŒ
ç¡é ž8.8ïœïŒ200ããªã¢ã«ïŒã滎äžãã宀枩ã§äžæ©
æ¹æãããã€ãã§ããããæ¹æããªããæ°·æ°Ž500
mlã«æ³šäžãã0.5æéæ¹æããå·åŽããªãã20ïŒ
æ°Žé žåãããªãŠã 氎溶液500mlãã€ãã§çé žæ°ŽçŽ
ãããªãŠã ãå ããŠäžåãããæ²ã§ãçæç©ãã¯
ãããã«ã ãå ããããšã«ãã€ãŠæº¶æ¶²ãšãããã
ã®æ··åç©ãã¯ãããã«ã 200mlã§ïŒåæœåºããã
æœåºæ¶²ãåãããæ°Ž200mlã§æŽæµããç¡æ°Žç¡«é žã
ããªãŠã äžã§ä¹Ÿç¥ããæžå§äžã§èžçºãããŠæ²¹ç¶ç²
çæç©ãåŸããããã€ãœãããããŒã«ãããã€ã
ã§ãšã¿ããŒã«ããåçµæ¶ãããŠç²Ÿè£œããïŒïŒïŒïŒ
ïŒïŒïŒâãžã¢ã³ãããââãã³ãããâïŒâã
ã€ãã¬ãŒãâïŒâãã³ãããŒã10.3ïœïŒ34.8ããª
ã¢ã«ïŒãåŸãã m.p.ïŒ132ã134â ãαã25 D264.3ïŒc0.5ïŒã¯ãããã«ã ïŒ å çŽ åæïŒC12H12N2O7ïŒïŒ296.24ïŒïŒ ãè¡šã ãã®çºæã®ååç©ã®è¬çåŠçæ§è³ªã調ã¹ãã«åœ
ããå¯Ÿç §ååç©ãšããŠåžè²©ã®ã€ãœãœã«ãããžãã€
ãã¬ãŒãïŒISDNïŒãããã³ã€ãœãœã«ããã¢ãã
ã€ãã¬ãŒãïŒISMNïŒïŒïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³
ãããââã°ã«ã·ããâïŒâãã€ãã¬ãŒãïŒã
åžžã«çšããã å åè貫æµå¢å€§å¹æã¯æåºãããã¢ã«ã¢ããã®
å¿èïŒã©ã³ã²ã³ãã«ãã«åŸãæåºå¿èããã³ã¬ãŒ
ä»Pflušger's ArchivïŒ353ïŒ317ã325ïŒ1975ïŒã«åŸ
ãæ¹æ³ïŒã«ã€ããŠèª¿ã¹ãã30ååŸã«å®åžžç¶æ ã«ãª
ã€ãŠãããåå¿èã«ãããã25ÎŒïœïŒmlã®è©Šéšå
åç©ãå«æããã¿ã€ããŒã液å50mlãæ³šå ¥ããã
åè©Šéšååç©ã¯ïŒåãïŒåã®å¿èã«ã€ããŠè©Šéšã
ãã ããããã®å Žåã«ã€ããŠãå€åæ§ã貫æµå¢å€§æ§
ããã³å¿æã調ã¹ããè¡šã«ç€ºãå€ã¯åæå€ã«å¯Ÿ
ããå¹³åå€åçïŒïŒ ïŒã§ããã è¡šã«ç€ºã枬å®å€ãæ¯èŒãããšããã®çºæã®å
åç©ã®å åè貫æµå¢å€§å¹æã¯ISMNããã倧ãã
ããšããããããã®çºæã®ååç©ã®ããã€ãã¯å¥œ
ãŸããå€åæ§ããã³å¿æäœäžäœçšã瀺ããŠããã ãè¡šã ãã«ã¢ãã¬ããªã³èªèµ·åçž®ããã³å¡©åã«ãªãŠã
èªèµ·åçž®ã®çããæåºããã©ãã倧åèã«ã€ããŠ
éçå¹æã調ã¹ãïŒãŠãšã³ãããã³ãã€ããŒã
Pflušnger's ArchivïŒ320ïŒ1970ïŒ133ã141ã«åŸã
æ¹æ³ïŒããã³ã¹ãããã«ãNaunynâScmiede
berg's Archiv of PharmacologyïŒSuppl.Vol.
308ïŒ1979ïŒR18ïŒãããã§ãå¯Ÿç §ååç©ãšããŠ
ISDNããã³ISMNãéžãã ã è¡šäžã«ã¯ççž®ã50ïŒ æå¶ããã«å¿ èŠãªè©Šéšå
åç©ã®ã¢ã«æ¿åºŠïŒED50å€ïŒã瀺ããŠããããã®
çºæã®ååç©ã®éçå¹æã¯ISMNãããè¯å¥œã§ã
ãŸãããã€ãã¯ISDNãããè¯å¥œã§ããã ãè¡šã è管å æäžã«ãã麻é åã¢ã«ã¢ããã«ã€ããŠã
ã®çºæã®ååç©ã®è¡å§éäžæ§ãISDNããã³
ISMNãšãšãã«èª¿ã¹ããè¡šã«ç€ºããå€ã¯ãã®çº
æã®ååç©ã¯ãã®ã»ãšãã©ãISMNããå¹æçã§
ãããå®æœäŸ2b ããã³5b ã®ååç©ãISDNãš
é¡äŒŒããŠããããšã瀺ããŠããã ãè¡šã ãè¡šã å®æœäŸ5bïŒã®ååç©ã®å€åæ§ããã³å¿ææ°äœ
äžå¹æãåäºæè žå æäžã«ãã€ãŠäœé2.5ã3.5Kg
ã®ã¢ã³ã°ã¬ã«ç«ã«ã€ããŠããã«èª¿ã¹ããç«ã¯ã¯ã
ã©ããŒã¹âãŠã¬ã¿ã³æ··åç©ïŒãŠã¬ã¿ã³1.2ïœïŒKg
ïŒã¯ãã©ããŒã¹40mgïŒKgè ¹è å æäžïŒã§éº»é åã
ãããã®ç«ã¯æ°ç®¡ã«ããŠãŒã¬ãéããŠèªç¶åŒåžã
ããå·Šå¿å®€ã«ã«ããŒãã«ãããããã¡ãŒã¿ãèšçœ®
ããããã«é åèãçšãããæ³šå ¥ã®ç®çã«é éè
ãçšãããå€§è ¿åèãä»ããŠã«ããŒãã«ãäžè¡å€§
åèäžã«æ¿å ¥ããè¡å§èšé²èšïŒStatham P23DbïŒ
ã«æ¥ç¶ãããå¿ææ°ããã«ã¹åšæ³¢æ°æž¬å®è£ 眮ïŒã
ãŠãŒãŽã»ã¶ãã¯ã¹ã»ãšã¬ã¯ããããã¯ç€Ÿè£œïŒã§å·Š
å¿å®€å§ä¿¡å·ããèšé²ãããåäºæè žã«ãŒããéè ¹
è¡ã«ããé²åºãããè©Šéšååç©ã¯çŽæ¥ç®¡å£ã«æ³šå ¥
ããã è¡šã«ç€ºãå€ããããã®çºæã®ååç©ã®è¡å§é
äžäœçšã¯ISDNãããè¯å¥œã§ããããšããããã ãè¡šã å¹³åå€ïŒæšæºèª€å·®ïŒïŒå¹ã®ç«çŸ€ïŒ
ãã®çºæã®ååç©ã®ããã€ãã«ã€ããŠæ¥æ§æ¯æ§
ã調ã¹ãããã«ãåååç©ãççé£å¡©æ°Žäžã§å¡©é ž
å¡©ã®åœ¢æ ã§éã®NMRIâã¢ã«ããããŠã¹ã«ãã
ãã100mlïŒKgããã³200mgïŒKgã®å²åã§éèå æ
äžãããåååç©ã¯äžæäžåœãå°ãªããšãäžå¹ã«
察ããŠæ³šå ¥ãããæ倧éæäžåŸã§ãæ»äº¡ããªãã€
ãå Žåã¯ãã以äžã®æäžã¯ãããªããªãã€ããç
åãçããå Žåã«ã¯ãåäžæäžéããã€ãŠããã«
å°ãªããšãïŒå¹ã«ã€ããŠå®éšãããè¿ãããæäž
åŸ24æé以å ã®æ»äº¡çã芳å¯ããã è¡šã«ã枬å®ããæ»äº¡çããã³ããããèšç®ã
ãLD50ç¯å²ã瀺ãã ãè¡šã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒ ïŒããã§ãã¯ããã²ã³çœ®æããšãã«åºãã¡ã¿
ã³ã¹ã«ããã«åºãŸãã¯ãã³ããã€ã«åºïŒã§ç€ºãã
ãïŒâããã³ïŒâ眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢
ã³ãããããã·ããã¢ããã€ãã¬ãŒãååç©ãã
ã³ïŒ²ããã³ããã€ã«åºã§ããå Žåã«ããããã®ç
çåŠçã«èš±å®¹ã§ããé žä»å å¡©ã ïŒ åŒ ïŒããã§ãã¯æ¢è¿°ã®ãšããïŒã§ç€ºãããïŒâ
眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãž
ããâïŒâãã€ãã¬ãŒãããã³ãã®ççåŠçã«èš±
容ã§ããé žä»å å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èš
èŒã®ååç©ããã³ãã®å¡©ã ïŒ åŒ ïŒããã§ãã¯æ¢è¿°ã®ãšããïŒã§ç€ºãããïŒâ
眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«
ã·ããâïŒâãã€ãã¬ãŒãããã³ãã®ççåŠçã«
蚱容ã§ããé žä»å å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
èšèŒã®ååç©ããã³ãã®å¡©ã ïŒ åŒ ïŒããã§ãã¯æ¢è¿°ã®ãšããïŒã§ç€ºãããïŒâ
眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«
ã·ããâïŒâãã€ãã¬ãŒãããã³ãã®ççåŠçã«
蚱容ã§ããé žä»å å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
èšèŒã®ååç©ããã³ãã®å¡©ã ïŒ åŒ ïŒããã§ãã¯æ¢è¿°ã®ãšããïŒã§ç€ºãããïŒâ
眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââãã³
ãããâïŒâãã€ãã¬ãŒãããã³ãã®ççåŠçã«
蚱容ã§ããé žä»å å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
èšèŒã®ååç©ããã³ãã®å¡©ã ïŒ ïŒââïŒïŒâã¯ããããšãã«ïŒâïŒïŒïŒïŒ
ïŒïŒïŒâãžã¢ã³ãããââã€ãžããâïŒâãã€
ãã¬ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®åå
ç©ã ïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžã
ãâïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒãã§ãã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâãã€ãã¬ãŒãâïŒâã¡ã¿ã³ã¹ã«ãããŒ
ãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·
ããâïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒãã§ã
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«
ã·ããâïŒâãã³ãããŒãâïŒâãã€ãã¬ãŒãã§
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââãã³
ãããâïŒâãã€ãã¬ãŒãâïŒâãã³ãããŒãã§
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââãã³
ãããâïŒâãã€ãã¬ãŒãâïŒâã¡ã¿ã³ã¹ã«ãã
ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ äžè¬åŒ ã§ç€ºãããïŒâããã³ïŒâ眮æïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããããã·ããã¢ããã€ãã¬ãŒãå
åç©ã§ãã€ãŠïŒ²ãã¡ã¿ã³ã¹ã«ããã«åºãŸãã¯ãã³
ããã€ã«åºã§ãããã®ã補é ããæ¹æ³ã§ãã€ãŠã
(A)âã€ãœã€ãžããâã€ãœãœã«ãããŸãã¯ïŒ€â
ã€ãœãã³ãããã¡ã¿ã³ã¹ã«ãã³é žã¯ããªããŸãã¯
ãã³ãã³é žã¯ããªããçšããŠçžå¿ããã¢ãââ
ã¢ã·ã«âïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããããã·ã
ãã«è»¢åãã(B)該ã¢ãââã¢ã·ã«âïŒïŒïŒïŒ
ïŒïŒïŒâãžã¢ã³ãããããã·ãããŸãã¯ããã«é ž
ãä»å ããŠåŸãããå¡©ãç¡é žãããã¯ç¡åæ§é žã
ãŸãã¯ç¡é žããã³æ°·é ¢é žïŒç¡æ°Žé ¢é žã®æ··åç©ã§ãš
ã¹ãã«åããŠçžå¿ããïŒâãŸãã¯ïŒââã¢ã·
ã«åïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããããã·ããã¢
ããã€ãã¬ãŒããåŸãããšãç¹åŸŽãšããæ¹æ³ã ïŒïŒ äžè¬åŒ ã§ç€ºãããïŒâããã³ïŒâ眮æïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããããã·ããã¢ããã€ãã¬ãŒãå
åç©ã§ãã€ãŠïŒ²ãã¡ã¿ã³ã¹ã«ããã«åºãŸãã¯ãã³
ããã€ã«åºã§ãããã®ã補é ããæ¹æ³ã§ãã€ãŠã
(a)âã€ãœã€ãžããâã€ãœãœã«ãããŸãã¯ïŒ€â
ã€ãœãã³ãããç¡é žãããã¯ç¡åæ§é žããŸãã¯ç¡
é žããã³æ°·é ¢é žïŒç¡æ°Žé ¢é žã®æ··åç©ãšåå¿ãããŠ
çžå¿ããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããããã·ã
ãã¢ããã€ãã¬ãŒããåŸã(b)ã€ãã§ãããã¡ã¿ã³
ã¹ã«ãã³é žã¯ããªããŸãã¯ãã³ãã³é žã¯ããªããš
åå¿ãããŠçžå¿ããïŒââãŸãã¯ïŒââã¢ã·
ã«åïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããããã·ããã¢
ããã€ãã¬ãŒããåŸãããšãç¹åŸŽãšããæ¹æ³ã ïŒïŒ äžè¬åŒ ã§ç€ºãããïŒâããã³ïŒâ眮æïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããããã·ããã¢ããã€ãã¬ãŒãå
åç©ã§ãã€ãŠïŒ²ãããããšãã«åºã§ãããã®ã補
é ããæ¹æ³ã§ãã€ãŠãïŒAâ²ïŒïŒ¬âã€ãœã€ãžãã
âã€ãœãœã«ãããŸãã¯ïŒ€âã€ãœãã³ãããã¹ã«ã
ã³é žã¯ããªããçšããŠçžå¿ããã¢ãââã¢ã·ã«
âïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããããã·ããã«è»¢
åããïŒBâ²ïŒãããææž©äžã§äºæ¥µæ§éãããã³æº¶
åªã®ååšäžã«ããã²ã³çœ®æããšããŒã«ã®åå¿æ§å¡©
ãšåå¿ãããããšã«ãã€ãŠç«äœé 眮ã®å転ã䌎ãª
ã€ãŠçžå¿ããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ããããã
ã·ããããããšãã«ãšãŒãã«ã«è»¢åããïŒCâ²ïŒã
ããåŸããããç¡é žãããã¯ç¡åæ§é žããŸãã¯ç¡
é žããã³æ°·é ¢é žïŒç¡æ°Žé ¢é žã®æ··åç©ãšåå¿ãããŠ
çžå¿ããïŒâãŸãã¯ïŒâ眮æïŒïŒïŒïŒïŒïŒïŒ
âãžã¢ã³ãããããã·ããã¢ããã€ãã¬ãŒããåŸ
ãããšãç¹åŸŽãšããæ¹æ³ã ïŒïŒ åŒãåŒããŸã㯠ãåŒãã§ç€ºãããååç©ã§ã〠ãŠïŒ²ããã³ããã€ã«åºã§ãããã®è£œé ããæ¹æ³ã§
ãã€ãŠãâã€ãœãœã«ãããŸãã¯ïŒ€âã€ãœãã³ã
ããã¹ã«ãã³é žã¯ããªããçšããŠïŒïŒïŒïŒïŒïŒïŒ
âãžã¢ã³ãããââã°ã«ã·ããâïŒâã¢ã·ã¬ãŒ
ããŸãã¯ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã
ã³ãããâïŒâã¢ã·ã¬ãŒãã«è»¢åããã€ãã§ãã
ããã³ãã³é žå¡©ãšææž©äžãäºæ¥µæ§éãããã³æº¶åª
äžã§åå¿ãããããšã«ãã€ãŠç«äœé 眮ã®å転ã䌎
ãªã€ãŠçžå¿ããïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã€ãžããâïŒâãã³ãããŒããŸãã¯ïŒïŒïŒïŒ
ïŒïŒïŒâãžã¢ã³ãããââã°ã«ã·ããâïŒâã
ã³ãããŒãã«è»¢åãããããåŸããããç¡é žãã
ãã¯ç¡åæ§é žããŸãã¯ç¡é žããã³ç¡æ°Žé ¢é žïŒé ¢é ž
ã®æ··åç©ã§ãšã¹ãã«åããŠçžå¿ããïŒïŒïŒïŒïŒïŒ
ïŒâãžã¢ã³ãããââã€ãžããâïŒâãã³ãã
ãŒãâïŒâãã€ãã¬ãŒããŸãã¯ïŒïŒïŒïŒïŒïŒïŒâ
ãžã¢ã³ãããââã°ã«ã·ããâïŒâãã³ãããŒ
ãâïŒâãã€ãã¬ãŒããåŸãããšãç¹åŸŽãšããæ¹
æ³ã ïŒïŒ äžè¬åŒ ïŒããã§ãã¯ããã²ã³çœ®æããšãã«åºãã¡ã¿
ã³ã¹ã«ããã«åºãŸãã¯ãã³ããã€ã«åºïŒã§ç€ºãã
ãïŒâããã³ïŒâ眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢
ã³ãããããã·ããã¢ããã€ãã¬ãŒãååç©ãã
ã³ïŒ²ããã³ããã€ã«åºã§ããå Žåã«ããããã®ç
çåŠçã«èš±å®¹ã§ããé žä»å å¡©ãæå¹æåãšããå
åèæµå¢å€§å€çµæç©ã ïŒïŒ ååç©ããã³ãã®å¡©ãåŒ ïŒããã§ãã¯æ¢è¿°ã®ãšããïŒã§ç€ºãããïŒâ
眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãž
ããâïŒâãã€ãã¬ãŒãããã³ãã®ççåŠçã«èš±
容ã§ããé žä»å å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé
èšèŒã®çµæç©ã ïŒïŒ ååç©ããã³ãã®å¡©ãåŒ ïŒããã§ãã¯æ¢è¿°ã®ãšããïŒã§ç€ºãããïŒâ
眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«
ã·ããâïŒâãã€ãã¬ãŒãããã³ãã®ççåŠçã«
蚱容ã§ããé žä»å å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒ
é èšèŒã®çµæç©ã ïŒïŒ ååç©ããã³ãã®å¡©ãåŒ ïŒããã§ãã¯æ¢è¿°ã®ãšããïŒã§ç€ºãããïŒâ
眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«
ã·ããâïŒâãã€ãã¬ãŒãããã³ãã®ççåŠçã«
蚱容ã§ããé žä»å å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒ
é èšèŒã®çµæç©ã ïŒïŒ ååç©ããã³ãã®å¡©ãåŒ ïŒããã§ãã¯æ¢è¿°ã®ãšããïŒã§ç€ºãããïŒâ
眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââãã³
ãããâïŒâãã€ãã¬ãŒãããã³ãã®ççåŠçã«
蚱容ã§ããé žä»å å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒ
é èšèŒã®çµæç©ã ïŒïŒ ååç©ãïŒââïŒïŒâã¯ããããšãã«ïŒâ
ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžããâ
ïŒâãã€ãã¬ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé
èšèŒã®çµæç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã€ãžããâïŒâãã€ãã¬ãŒãâïŒâãã³ãã
ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®çµæ
ç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã°ã«ã·ããâïŒâãã€ãã¬ãŒãâïŒâã¡ã¿ã³
ã¹ã«ãããŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒ
ã®çµæç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã°ã«ã·ããâïŒâãã€ãã¬ãŒãâïŒâãã³ã
ããŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®çµæ
ç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã°ã«ã·ããâïŒâãã³ãããŒãâïŒâãã€ã
ã¬ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®çµæ
ç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âãã³ãããâïŒâãã€ãã¬ãŒãâïŒâãã³ã
ããŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®çµæ
ç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âãã³ãããâïŒâãã€ãã¬ãŒãâïŒâã¡ã¿ã³
ã¹ã«ãããŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒ
ã®çµæç©ã ïŒïŒ äžè¬åŒ ïŒããã§ãã¯ããã²ã³çœ®æããšãã«åºãã¡ã¿
ã³ã¹ã«ããã«åºãŸãã¯ãã³ããã€ã«åºïŒã§ç€ºãã
ãïŒâããã³ïŒâ眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢
ã³ãããããã·ããã¢ããã€ãã¬ãŒãååç©ãã
ã³ïŒ²ããã³ããã€ã«åºã§ããå Žåã«ããããã®ç
çåŠçã«èš±å®¹ã§ããé žä»å å¡©ãæå¹æåãšããé®
çå€çµæç©ã ïŒïŒ ååç©ããã³ãã®å¡©ãåŒ ïŒããã§ãã¯æ¢è¿°ã®ãšããïŒã§ç€ºãããïŒâ
眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãž
ããâïŒâãã€ãã¬ãŒãããã³ãã®ççåŠçã«èš±
容ã§ããé žä»å å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé
èšèŒã®çµæç©ã ïŒïŒ ååç©ããã³ãã®å¡©ãåŒ ïŒããã§ãã¯æ¢è¿°ã®ãšããïŒã§ç€ºãããïŒâ
眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«
ã·ããâïŒâãã€ãã¬ãŒãããã³ãã®ççåŠçã«
蚱容ã§ããé žä»å å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒ
é èšèŒã®çµæç©ã ïŒïŒ ååç©ããã³ãã®å¡©ãåŒ ïŒããã§ãã¯æ¢è¿°ã®ãšããïŒã§ç€ºãããïŒâ
眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«
ã·ããâïŒâãã€ãã¬ãŒãããã³ãã®ççåŠçã«
蚱容ã§ããé žä»å å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒ
é èšèŒã®çµæç©ã ïŒïŒ ååç©ããã³ãã®å¡©ãåŒ ïŒããã§ãã¯æ¢è¿°ã®ãšããïŒã§ç€ºãããïŒâ
眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââãã³
ãããâïŒâãã€ãã¬ãŒãããã³ãã®ççåŠçã«
蚱容ã§ããé žä»å å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒ
é èšèŒã®çµæç©ã ïŒïŒ ååç©ãïŒââïŒïŒâã¯ããããšãã«ïŒâ
ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžããâ
ïŒâãã€ãã¬ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé
èšèŒã®çµæç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã€ãžããâïŒâãã€ãã¬ãŒãâïŒâãã³ãã
ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®çµæ
ç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã°ã«ã·ããâïŒâãã€ãã¬ãŒãâïŒâã¡ã¿ã³
ã¹ã«ãããŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒ
ã®çµæç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã°ã«ã·ããâïŒâãã€ãã¬ãŒãâïŒâãã³ã
ããŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®çµæ
ç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã°ã«ã·ããâïŒâãã³ãããŒãâïŒâãã€ã
ã¬ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®çµæ
ç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âãã³ãããâïŒâãã€ãã¬ãŒãâïŒâãã³ã
ããŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®çµæ
ç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âãã³ãããâïŒâãã€ãã¬ãŒãâïŒâã¡ã¿ã³
ã¹ã«ãããŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒ
ã®çµæç©ã ïŒïŒ äžè¬åŒ ïŒããã§ãã¯ããã²ã³çœ®æããšãã«åºãã¡ã¿
ã³ã¹ã«ããã«åºãŸãã¯ãã³ããã€ã«åºïŒã§ç€ºãã
ãïŒâããã³ïŒâ眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢
ã³ãããããã·ããã¢ããã€ãã¬ãŒãååç©ãã
ã³ïŒ²ããã³ããã€ã«åºã§ããå Žåã«ããããã®ç
çåŠçã«èš±å®¹ã§ããé žä»å å¡©ãæå¹æåãšããè¡
å§éäžå€çµæç©ã ïŒïŒ ååç©ããã³ãã®å¡©ãåŒ ïŒããã§ãã¯æ¢è¿°ã®ãšããïŒã§ç€ºãããïŒâ
眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãž
ããâïŒâãã€ãã¬ãŒãããã³ãã®ççåŠçã«èš±
容ã§ããé žä»å å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé
èšèŒã®çµæç©ã ïŒïŒ ååç©ããã³ãã®å¡©ãåŒ ïŒããã§ãã¯æ¢è¿°ã®ãšããïŒã§ç€ºãããïŒâ
眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«
ã·ããâïŒâãã€ãã¬ãŒãããã³ãã®ççåŠçã«
蚱容ã§ããé žä»å å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒ
é èšèŒã®çµæç©ã ïŒïŒ ååç©ããã³ãã®å¡©ãåŒ ïŒããã§ãã¯æ¢è¿°ã®ãšããïŒã§ç€ºãããïŒâ
眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã°ã«
ã·ããâïŒâãã€ãã¬ãŒãããã³ãã®ççåŠçã«
蚱容ã§ããé žä»å å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒ
é èšèŒã®çµæç©ã ïŒïŒ ååç©ããã³ãã®å¡©ãåŒ ïŒããã§ãã¯æ¢è¿°ã®ãšããïŒã§ç€ºãããïŒâ
眮æïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââãã³
ãããâïŒâãã€ãã¬ãŒãããã³ãã®ççåŠçã«
蚱容ã§ããé žä»å å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒ
é èšèŒã®çµæç©ã ïŒïŒ ååç©ãïŒââïŒïŒâã¯ããããšãã«ïŒâ
ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããââã€ãžããâ
ïŒâãã€ãã¬ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé
èšèŒã®çµæç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã€ãžããâïŒâãã€ãã¬ãŒãâïŒâãã³ãã
ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®çµæ
ç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã°ã«ã·ããâïŒâãã€ãã¬ãŒãâïŒâã¡ã¿ã³
ã¹ã«ãããŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒ
ã®çµæç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã°ã«ã·ããâïŒâãã€ãã¬ãŒãâïŒâãã³ã
ããŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®çµæ
ç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âã°ã«ã·ããâïŒâãã³ãããŒãâïŒâãã€ã
ã¬ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®çµæ
ç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âãã³ãããâïŒâãã€ãã¬ãŒãâïŒâãã³ã
ããŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®çµæ
ç©ã ïŒïŒ ååç©ãïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ãããâ
âãã³ãããâïŒâãã€ãã¬ãŒãâïŒâã¡ã¿ã³
ã¹ã«ãããŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒ
ã®çµæç©ã
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3028289A DE3028289C2 (de) | 1980-07-25 | 1980-07-25 | 2-O- und 5-O-substituierte 1.4;3.6-Dianhydro-hexit-mononitrate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5753488A JPS5753488A (en) | 1982-03-30 |
| JPS637549B2 true JPS637549B2 (ja) | 1988-02-17 |
Family
ID=6108129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56116322A Granted JPS5753488A (en) | 1980-07-25 | 1981-07-24 | 2-o and 5-o substituted 1,4;3,6- dianhydrohexitol mononitrate compound, manufacture and drug composition |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4364953A (ja) |
| EP (1) | EP0044931B1 (ja) |
| JP (1) | JPS5753488A (ja) |
| AT (1) | ATE12643T1 (ja) |
| CA (1) | CA1184916A (ja) |
| DE (1) | DE3028289C2 (ja) |
| ES (1) | ES503920A0 (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01262171A (ja) * | 1988-04-13 | 1989-10-19 | Nec Corp | ããªã³ã¿ |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3248548A1 (de) * | 1982-12-29 | 1984-07-05 | Heinrich Mack Nachf., 7918 Illertissen | Acylderivate von 1,4:3,6-dianhydro-hexiten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| ES2142773B1 (es) * | 1998-10-07 | 2001-01-01 | Lacer Sa | Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida. |
| EP2149576A1 (en) * | 2008-07-22 | 2010-02-03 | Lacer, S.A. | Isosorbide Nitrates having vasodilating activity |
| EP2199294A1 (en) * | 2008-12-19 | 2010-06-23 | Lacer, S.A. | New stereospecific method for the preparation of dioxa bicyclooctane nitrate compounds |
| WO2014200636A1 (en) * | 2013-06-12 | 2014-12-18 | Archer Daniels Midland Company | Synthesis of dicarbamates from reduction products of 2-hydroxymethyl-5-furufural (hmf) and derivatives thereof |
| EP3273951B1 (en) | 2015-03-27 | 2020-07-29 | Symbionyx Pharmaceuticals Inc. | Compositions and methods for treating psoriasis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1027891A (en) * | 1962-01-02 | 1966-04-27 | Aspro Nicholas Ltd | Esters of dianhydro-hexitols |
| US3886186A (en) * | 1971-04-29 | 1975-05-27 | American Home Prod | Mononitrate esters of 1,4:3,6-dianhydro-d-glucitol |
| GB1356374A (en) * | 1971-04-29 | 1974-06-12 | American Home Prod | Mononitrate esters of 1,3 3,6-dianhydro-d-glucitol |
| US4169152A (en) * | 1977-10-31 | 1979-09-25 | Ici Americas Inc. | Isohexide and tetrahydrofuran ethers and their carbamates in method of bringing about relaxation of skeletal musculature |
| DE2903927C2 (de) * | 1979-02-02 | 1981-03-12 | Sanol Schwarz-Monheim Gmbh, 4019 Monheim | Verfahren zur selektiven Herstellung von Isosorbid-5-nitrat |
-
1980
- 1980-07-25 DE DE3028289A patent/DE3028289C2/de not_active Expired
-
1981
- 1981-06-13 AT AT81104568T patent/ATE12643T1/de not_active IP Right Cessation
- 1981-06-13 EP EP81104568A patent/EP0044931B1/de not_active Expired
- 1981-07-08 CA CA000381314A patent/CA1184916A/en not_active Expired
- 1981-07-13 ES ES503920A patent/ES503920A0/es active Granted
- 1981-07-20 US US06/285,407 patent/US4364953A/en not_active Expired - Fee Related
- 1981-07-24 JP JP56116322A patent/JPS5753488A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01262171A (ja) * | 1988-04-13 | 1989-10-19 | Nec Corp | ããªã³ã¿ |
Also Published As
| Publication number | Publication date |
|---|---|
| DE3028289A1 (de) | 1982-02-25 |
| ES8403911A1 (es) | 1984-04-16 |
| EP0044931A1 (de) | 1982-02-03 |
| EP0044931B1 (de) | 1985-04-10 |
| JPS5753488A (en) | 1982-03-30 |
| US4364953A (en) | 1982-12-21 |
| CA1184916A (en) | 1985-04-02 |
| DE3028289C2 (de) | 1986-11-27 |
| ES503920A0 (es) | 1984-04-16 |
| ATE12643T1 (de) | 1985-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN116082303B (zh) | æ°å氧代å¡å¶ç±»ååç©åå ¶äžéŽäœååºçš | |
| US5366997A (en) | Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs | |
| JP6298768B2 (ja) | ïŒâ眮æãã³ãã¡ã³ã®ãã³ïœèªå°äœããã®èª¿è£œæ¹æ³åã³äœ¿çš | |
| US4622324A (en) | 1.4;3.6-Dianhydrohexitol nitrates substituted by purine bases, and pharmaceutical compositions | |
| KR100281867B1 (ko) | 3-(ë¹ì€-ì¹ííëë©ížë )ì¥ì ëì ë첎 | |
| EP0066242B1 (en) | Tocopheryl ester of 5-substituted picolinic acid, process for its production, and pharmaceutical composition containing it | |
| KR20180073517A (ko) | ížëŠ¬ííšëŠ¬ëì c14-íëë¡ì€ ìì€í 륎í ìë¯žë žì° ì ë첎, ë° ê·žì ì ì¡° ë°©ë² ë° ì©ë | |
| JP2011528691A (ja) | è¡ç®¡æ¡åŒµæŽ»æ§ãæããç¡é žã€ãœãœã«ãã | |
| JPS5943959B2 (ja) | ã€ãœãœã«ããâïŒâããã¬âãã®éžæç補é æ³ | |
| US4364953A (en) | 2-0- and 5-0-Substituted 1.4;3.6-dianhydrohexitol mononitrates and pharmaceutical composition | |
| JP2539734B2 (ja) | ãã§ãã«ã¢ã«ã«ã³é žãšã¹ãã« | |
| JPWO2001027115A1 (ja) | äºç°æ§ã¿ããµã³ååç© | |
| JPH0352465B2 (ja) | ||
| US4542137A (en) | Alkylaminodesoxy-1.4;3.6-dianhydrohexitol nitrates substituted by purine bases and pharmaceutical compositions | |
| JP2023523630A (ja) | ã€ãã·ããŒã«èªå°äœåã³ãã®äœ¿çš | |
| JPS604177B2 (ja) | ãã³ãŸãã©ã³èªå°äœã®è£œé æ¹æ³ | |
| JPS63297383A (ja) | ïŒïŒïŒïŒïŒïŒïŒâãžã¢ã³ããããœã«ãããŒã«ãïŒâã¢ãããã¬ãŒããåã³ãïŒâãããã¬ãŒããšã¹ãã«ãããããšã¹ãã«ã®è£œé æ¹æ³ãåã³ããããšã¹ãã«ãããªãè¬å€çµæç© | |
| CN103204861A (zh) | æ°å代é·å ¬è€å é ¯è¡çç©åå ¶å¶å€æ¹æ³ååºçš | |
| CN118908950B (zh) | äžç§çšäºæ²»çå¿è¡ç®¡çŸç çè¯ç©åå ¶å¶å€æ¹æ³ | |
| US4044012A (en) | Indolo-quinolizidine derivatives | |
| US3971798A (en) | Pyridine derivative, processes of preparation and pharmaceutical compositions | |
| DD283625A5 (de) | Verfahren zur herstellung von aminopropanol-derivaten von 1,4:3,6-dianhydro-hexit-nitraten | |
| US5120737A (en) | Hexitol derivatives | |
| JPS5821634B2 (ja) | ã·ã³ãã€ãã㟠ïŒïŒïŒïŒâïœïŒïœâ ããªã¢ãžã³ã«ã€ãã»ã€ãŸãŠããŠã㊠| |
| JPH1129471A (ja) | ã¯ããªã³èªå°äœãè¬å¹æåãšããŠå«æããèçŸæ£æ²»çå€ |